Theory of mind in individuals with paranoid schizophrenia by Scott, Suzanne (Liesbeth)
Glasgow Theses Service 
http://theses.gla.ac.uk/ 
theses@gla.ac.uk 
 
 
 
 
 
Scott, Suzanne (Liesbeth) (2013) Theory of mind in individuals with 
paranoid schizophrenia. D Clin Psy thesis. 
 
 
 
http://theses.gla.ac.uk/4686/ 
 
 
 
Copyright and moral rights for this thesis are retained by the author 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge 
 
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author 
 
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
 
  
 1 
 
 
 
 
 
Theory of mind in individuals with paranoid schizophrenia 
 
 
 
Clinical Research Portfolio 
 
 
Volume 1 
 
(Volume 2 bound separately) 
 
 
 
 
 
 
 
 
 
 
Liesbeth Scott 
 
 
Submitted in partial fulfilment of the requirements for the degree of Doctorate 
in Clinical Psychology (D Clin Psy) 
 
Academic Unit of Mental Health and Wellbeing 
Institute of Health and Wellbeing 
University of Glasgow 
 
August 2013 
 
 
 
©Liesbeth Scott, 2013 
  
 2 
 
ACKNOWLEDGEMENTS 
 
 
I would like to thank Dr Sue Turnbull for her guidance in supervising my 
research portfolio, and Dr Allison Blackett for her help with recruitment. I 
really appreciated all the support that I received from you both. Thank you 
also to all those who participated in the study, and the NHS staff who 
facilitated the project.   
 
 
 
Most of all, I would like to thank Duncan. I would not have been able to do 
this without you. Thank you for everything, all the support and 
encouragement that you have given me and the sacrifices that you have 
made. Thank you also to our wonderful families and friends who have been 
there throughout. I promise not to do anything like this again! 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 3 
  
 
Declaration of Originality Form  
This form must be completed and signed and submitted with all assignments. 
Please complete the information below (using BLOCK CAPITALS). 
Name Liesbeth Scott ..................................................................................................................................  
Student Number ........................................................................................................................................  
Course Name Doctorate in Clinical Psychology .........................................................................................  
Assignment Number/Name Theory of mind in individuals with paranoid schizophrenia and 
clinical research portfolio ..........................................................................................................................  
An extract from the University’s Statement on Plagiarism is provided overleaf.  Please 
read carefully THEN read and sign the declaration below. 
I confirm that this assignment is my own work and that I have: 
Read and understood the guidance on plagiarism in the Student Handbook, including 
the University of Glasgow Statement on Plagiarism 
 
Clearly referenced, in both the text and the bibliography or references, all sources 
used in the work  
 
Fully referenced (including page numbers) and used inverted commas for all text 
quoted from books, journals, web etc. (Please check with the Department which 
referencing style is to be used) 
 
Provided the sources for all tables, figures, data etc. that are not my own work  
Not made use of the work of any other student(s) past or present without 
acknowledgement.  This includes any of my own work, that has been previously, or 
concurrently, submitted for assessment, either at this or any other educational 
institution, including school (see overleaf at 31.2) 
 
Not sought or used the services of any professional agencies to produce this work  
In addition, I understand that any false claim in respect of this work will result in 
disciplinary action in accordance with University regulations 
 
  
  
 4 
DECLARATION: 
I am aware of and understand the University’s policy on plagiarism and I certify that this 
assignment is my own work, except where indicated by referencing, and that I have 
followed the good academic practices noted above 
Signed Liesbeth Scott .................................................................................................................................  
 
 
   
 
  
 5 
  TABLE OF CONTENTS 
  
Chapter 1: Systematic Review 7  
 A systematic review of the evidence for Metacognitive Training for 
individuals with schizophrenia 
 
 
Chapter 2: Major Research Project 47  
 Theory of mind in individuals with paranoid schizophrenia 
 
 
Chapter 3: Advanced Clinical Practice  90 
 Reflective Account 1 (abstract only)  
 The role of communication in increasing the availability and 
provision of evidence based psychological therapies 
 
 
Chapter 4: Advanced Clinical Practice 92  
 Reflective Account 2 (abstract only)  
 Training formulation skills in clients, other professionals and the 
multidisciplinary team – the idea of ‘chipping in’ 
 
 
Appendices 94 
 1.0 
1.1 
2.0 
2.1 
2.2 
2.3 
Schizophrenia Research author guidelines 
Clinical Trials Assessment Measure scores 
Eyes Test pilot 
New Theory of Mind Measure pilot 
New Theory of Mind Measure example item 
New Theory of Mind Measure manual 
94 
104 
106 
107 
108 
109 
  
 6 
2.4 
2.5 
2.6 
2.7 
 
2.8 
2.9 
 
2.10 
Ethics approval 
NHS Research and Development approval  
Ethics approval of major amendment 
NHS Research and Development approval of major 
amendment 
Eyes Test distracter items 
New Theory of Mind Measure analysis according to 
components 
Major Research Project proposal 
123 
126 
128 
130 
 
131 
132 
 
134 
  
 7 
CHAPTER 1 
Systematic Review 
 
 
A systematic review of the evidence for Metacognitive Training for 
individuals with schizophrenia 
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 Abstract 
The evidence for Metacognitive Training (MCT) for individuals with 
schizophrenia on positive symptoms and the jumping to conclusions 
reasoning error was systematically evaluated. Nine studies met the inclusion 
and exclusion criteria. Overall methodological quality was poor and the 
majority of studies lacked power to detect differences. The ability to compare 
studies was negatively impacted by variations in how MCT was delivered, 
assessed and reported. There is emerging evidence that MCT can reduce 
positive symptoms. However, the evidence from three studies that fully 
evaluated this was conflicting, and a meta-analysis indicated a small overall 
effect size (d = 0.29; 95% CI -0.18 – 0.77) and did not provide clear support 
for the efficacy of MCT. Similarly, there is emerging evidence for the 
effectiveness of MCT in reducing the jumping to conclusions reasoning error. 
The evidence from one study for MCT augmented with individual 
metacognitive therapy was the most promising. The limitations of this review 
and recommendations for future research are discussed.   
 
Keywords: metacognitive training, schizophrenia, positive symptoms, 
jumping to conclusions bias. 
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1. Introduction 
1.1 Schizophrenia and social cognition 
Schizophrenia is a severe and disabling disorder that disturbs perception, is 
frequently associated with impaired cognition and emotion, and has 
pervasive effects on an individual’s well-being, psychosocial functioning and 
life opportunities (NICE, 2010; Tarrier and Wykes, 2004). Social cognition, 
which refers to the cognitive processes that are involved in perceiving and 
understanding social situations, particularly the behaviours and intentions of 
others, is also consistently impaired in individuals with serious mental illness 
(Fizdon and Reddy, 2012; Penn et al., 2008).  
 
There is as yet no consensus on the number of domains in social cognition, 
however, in a recent review, Fizdon and Reddy (2012), described five 
domains consisting of emotion processing, social perception, social 
knowledge, theory of mind (ToM) and attributional bias. Emotion processing 
involves the identification of emotions, and also refers to the ability to 
understand and manage emotions (Fizdon and Reddy, 2012). Social 
perception refers to the ability to make inferences about social situations, 
and the ability to discern relevant person-related features related to status, 
mood state, relationship or veracity (Fizdon and Reddy, 2012). ToM refers to 
the cognitive capacity to represent one’s own and other’s mental states, for 
instance, the ability to infer the intentions, beliefs and opinions of self and 
others (Brüne, 2005). Attributional bias refers to the negative explanations 
that individuals generate regarding other people’s behaviours and their 
interactions (Fizdon and Reddy, 2012).  
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1.2 Interventions  
The primary treatment for schizophrenia is antipsychotic medication, 
however there are a number of limitations associated with their use. These 
include poor response to first-generation or typical antipsychotic drugs; a 
high incidence and broad range of side effects to typical and second-
generation or atypical antipsychotic drugs; patient resistance; and, problems 
with medication compliance (NICE 2010). In response to these limitations, 
and in growing recognition of the importance of psychological processes in 
psychosis, psychological therapies, psychosocial and social cognitive 
interventions have been the subject of increased research activity.  
 
The use of Cognitive Behaviour Therapy for psychosis (CBTp) in the 
treatment of schizophrenia is now well-established (Tarrier and Wykes, 
2004). Tarrier and Wykes (2004) reviewed 20 randomised controlled trials 
(RCTs), and concluded that CBTp was associated with modest effect sizes. 
In addition to established approaches like CBTp, there is currently a focus on 
the development of social cognitive treatments for schizophrenia. This 
reflects the significant social cognitive deficits that have been evidenced in 
schizophrenia (Penn et al., 2008), but also the fact that they are amenable to 
intervention (Fizdon and Reddy, 2012). Social cognitive interventions for 
schizophrenia can be classified according to whether they are targeted 
(focused on a single social cognitive domain), comprehensive (focused 
solely on social cognition in the absence of any other psychosocial 
treatments, and addressing a range of social cognitive impairments within a 
single treatment modality) or broad-based (addressing multiple social 
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cognitive domains within the context of other psychosocial treatment) (Fizdon 
and Reddy, 2012).  
 
Metacognitive Training (MCT), a comprehensive social cognitive intervention, 
is a group, manualised approach that is delivered across eight sessions. It 
targets the social cognitive biases that are thought to underpin the formation 
and maintenance of psychotic symptoms, especially delusions (Moritz et al., 
2005; Moritz et al., 2011b). MCT focuses upon general types of reasoning 
errors including attributional bias, jumping to conclusions (JTC) bias, bias 
against disconfirmatory evidence, ToM impairments, overconfidence in 
memory errors, and depressive cognitive patterns (Moritz et al., 2005). It 
aims to raise awareness in participants of cognitive biases, and how these 
might relate to psychotic symptoms and negative consequences (Moritz et 
al., 2011a; Moritz et al., 2011b).  
 
Fizdon and Reddy (2012) recently conducted a review of social cognitive 
treatments for psychosis. Whilst MCT was amongst the approaches that 
were reviewed, Fizdon and Reddy (2012) did not conduct a systematic 
review of the literature and did not consider the methodological quality of 
included studies. To the best knowledge of the author, there has been no 
systematic review of the evidence for MCT. The current review seeks to 
address this gap, and in doing so will evaluate the evidence for MCT for 
individuals with schizophrenia. Specifically, the review will focus on 
evaluating the effect of MCT on the positive symptoms of schizophrenia and 
the jumping to conclusions bias. 
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2. Methods 
2.1 Search Strategy 
Mental health related bibliographic databases including Excerpta Medica 
Database (EMBASE) (via OVID), Medical Literature Analysis and Retrieval 
System Online (MEDLINE) (via OVID), Cumulative Index to Nursing and 
Allied Health Literature (CINAHL) (via EBSCO), PsychINFO (via EBSCO), 
Psychology and Behavioural Sciences Collection (via EBSCO), Web of 
Science, SCOPUS and the Cochrane Library were searched electronically. 
The search was restricted to 2005 onwards, which reflected the availability of 
MCT. The electronic database search employed the following search criteria 
(please note that search terms are separated by Boolean search operators 
OR and AND):  
(metacog* near/2 train*) OR metacog* OR “cognitive bias” OR “cognitive 
trap$” OR “social cognition” OR “jumping to conclusions bias” 
AND 
Schizo* OR psychosis OR “positive symptom$” OR delusion$ OR 
hallucination$ OR (chronic* near/2 ill*) OR (chronic* near/2 disorder*) OR 
(sever* near/2 ill*) OR (sever* near/2 disorder*).  
 
Search criteria symbols for truncation symbols, wildcards and adjacent 
searches were modified according to the database employed. The following 
journals were hand-searched: Behavioural Cognitive Psychotherapy, 
Behaviour Research and Therapy, BMC Research Notes (from 2008 only), 
European Psychiatry, European Journal of Psychotherapy and Counselling, 
Current Opinion in Psychiatry, Journal of Advanced Nursing, Journal of 
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Behaviour Therapy and Experimental Psychiatry, Psychological Medicine, 
Schizophrenia Bulletin and Schizophrenia Research. The electronic 
database search and hand-search of journals was conducted in May 2013. 
Search results were initially screened for potential relevance using the title, 
abstract and keywords of articles. Those articles initially selected were 
subsequently reviewed in greater detail to determine whether they referred to 
MCT by accessing the full text of the article where possible. Inclusion and 
exclusion criteria were subsequently applied.  
 
 
2.2 Inclusion and Exclusion Criteria 
The following inclusion criteria were applied:  
 Employs MCT modules 
 Intervention targets individuals with a schizophrenia spectrum disorder 
 Examines outcome on general psychopathology and/or social cognitive 
biases 
 Any age group 
 Published in English 
 
The following exclusion criteria were applied:  
 Case studies 
 Unpublished studies or books 
 Other psychiatric diagnoses 
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2.3 Methodological Quality 
The Clinical Trials Assessment Measure (CTAM) (Tarrier and Wykes, 2004) 
was employed to assess methodological quality. It is designed to assess 
methodological quality in psychological trials, and is composed of 15 items 
grouped into six areas of trial design including sample size and recruitment 
method, allocation to treatment, assessment of outcome, control groups, 
description of treatments and analysis. The CTAM shows good blind inter-
rater agreement, concurrent validity, and adequate internal consistency 
(Tarrier and Wykes, 2004). Two reviewers independently assessed the 
articles, and any disagreement in scoring was resolved by discussion. 
  
 
2.4 Data extraction  
A data form was developed to extract study information including study 
design, intervention, sample size, outcome measures employed and main 
results. Effect sizes were reported or calculated using an online effect size 
calculator (Becker, 2000). Effect sizes are reported as Cohen’s d, with d = 
0.2 a small effect, d = 0.5 a medium effect and d = 0.8 a large effect (Cohen, 
1988).  
 
 
2.5 Method of data synthesis 
A qualitative synthesis of the included studies was conducted. There was 
heterogeneity across studies in the measurement of general 
psychopathology, however the Positive and Negative Syndrome Scale 
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(PANSS) (Kay et al., 1987) was the most frequently reported measure. 
Results on the PANSS positive subscale or on individual items from this 
subscale were considered. This aspect was selected as MCT targets the 
social cognitive biases that contribute to the formation and/ or maintenance 
of schizophrenia, in particular delusions (Moritz et al., 2011b). A meta-
analysis of three studies that employed full MCT and provided sufficient data 
on outcome on the positive PANSS subscale was conducted using software 
provided by Cumming (2012). The meta-analysis examined the effect size for 
the difference between intervention and control group on the change in 
positive PANSS score. MCT focuses upon general types of reasoning errors, 
however JTC was most frequently assessed and was therefore selected to 
compare studies. Most studies employed the ‘Beads Task’ (Garety et al., 
1991) or variations of this task to assess JTC. The key variables were the 
number of beads drawn and whether or not a JTC bias was shown. 
 
 
 
3. Results 
3.1 Study selection 
The search strategy returned 4217 results. An initial screen yielded 494 
items, which when de-duplicated, resulted in 451 articles requiring further 
scrutiny. Articles were further screened by accessing the full text where 
possible, which led to 22 items being identified. In a parallel process, a hand 
search of journals returned one new result. Following the application of the 
inclusion and exclusion criteria, nine studies were considered appropriate for 
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inclusion. Figure 1 illustrates the article selection process and is based on 
Preferred Reporting Items for Systematic reviews and Meta-Analyses 
(PRISMA) (Moher et al., 2009). 
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Results identified through database 
searching n = 4217. 
 
(CINAHL via EBSCO = 78; Psychology and 
Behavioural Sciences Collection via EBSCO 
= 182; PsychINFO via EBSCO = 822; 
Medline and Embase via OVID = 1164; 
Cochrane Library = 40; Web of Science = 
1,042; SCOPUS = 989). 
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Additional results identified 
through other sources – hand 
search of journals n = 1. 
Results initially screened using title, abstract and keywords n = 495.  
 
(CINAHL via EBSCO = 17; Psychology and Behavioural Sciences Collection via 
EBSCO = 13; PsychINFO via EBSCO = 104; Medline and Embase via OVID = 
147; Cochrane Library = 18; Web of Science = 97; SCOPUS = 98). 
Full-text accessed to determine if 
MCT modules employed n = 452.         
Records excluded 
n = 429. 
Scrutiny of studies to apply full 
inclusion and exclusion criteria n = 
23. 
Full-text articles excluded n = 14. 
 
Reasons for exclusion: not in English 
(3); conference or meeting abstract (5); 
not appropriate diagnosis (1); review or 
other publication (2); case study (1); 
outcome measure not relevant (1).  
 
Studies included in qualitative synthesis n = 9 
 
Five studies employed MCT (Aghotor et al., 2010; Favrod et al., 2010; Kumar et al., 
2010; Moritz et al., 2011a; Naughton et al., 2012). One study augmented MCT 
(Moritz et al., 2011b). Three studies employed two or less modules of MCT as part 
of a wider non-MCT intervention, or heavily adapted MCT modules (Lecardeur et 
al., 2009; Ross et al., 2011; Waller et al., 2011). 
Records after duplicates removed n = 452. 
 
 
Figure 1: Article selection process. 
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3.2 Study characteristics 
Table 1 provides details of the nine reviewed studies. Seven studies included 
participants with a schizophrenia spectrum disorder diagnosis. Kumar et al. 
(2010) specified a diagnosis of paranoid schizophrenia, whilst Naughton et 
al. (2012) specified a psychotic disorder (including a diagnosis of 
schizophrenia). Study participants were adults, aged 16 – 65 years. Five 
studies were RCTs. Five studies employed MCT as described in Section 1.2 
(full MCT) (Aghotor et al., 2010; Favrod et al., 2010; Kumar et al., 2010; 
Moritz et al., 2011a; Naughton et al., 2012). Moritz et al. (2011b) provided 
MCT and additional individual metacognitive therapy (augmented MCT), 
whilst three studies incorporated modules of MCT in a wider program or 
adapted modules of MCT in a wider intervention (modules of MCT) 
(Lecardeur et al., 2009; Ross et al., 2011; Waller et al., 2011). Across 
studies, 140 participants received an intervention employing MCT, and data 
were analysed for 129 of these participants.  
 
 
3.3 Methodological quality 
The CTAM (Tarrier and Wykes, 2004) was employed to evaluate the 
methodological quality of the studies identified (Appendix 1.1). There was 
86.89% agreement across items between two independent raters of the 
papers, and following discussion to resolve any differences in scoring, 100% 
agreement was reached. The main areas for discussion were whether the 
process of randomisation and the methods of rater blinding were adequately 
described. The median score for the nine studies was 44 (Range 17 – 68). 
  
 19 
There was variation in the quality of studies, predominantly in the areas of 
allocation of participants and use of control groups. CTAM score was used to 
categorise the methodological quality of studies as ‘very poor’ (0-20), ‘poor’ 
(21- 40), ‘moderate’ (41 – 60), ‘good’ (61 – 80) and ‘very good’ (81 – 100).  
 
 
3.4 Synthesis of studies 
Studies are considered according to how MCT was employed (Section 3.2) 
and in order of methodological quality. Table 1 summarises the studies’ 
methodological quality and key findings.  
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Table 1: Summary of studies in relation to methodological quality and key findings. 
 
 
Study 
 
Methodological 
quality  
 
Design, intervention 
and sample size 
 
Main results  
 
 
Full Metacognitive Training Programme 
 
Moritz et 
al., 2011a 
CTAM: 64/100 
 
Strengths:  
blinded randomisation; 
blinded assessments; 
use of TAU control 
group. 
 
Weaknesses:  
no active control group; 
no correction for 
multiple t – tests.  
RCT 
 
MCT n = 18 v wait-list 
group receiving 
treatment as usual n = 
18. 
 
 
PANSS  
No significant difference between groups on the change in PANSS 
positive subscale scores, although a small to medium between group 
effect was reported (d < 0.38).   
  
JTC  
JTC assessed with computerised variant of the ‘Beads Task’ (Moritz et 
al., 2011a). No significant difference between groups in draws to 
decision score, although a medium effect in favour of the MCT group 
was reported (d = 0.52). No significant difference between groups in the 
rate of JTC bias between groups, although a small to medium effect in 
favour of MCT was reported (d = 0.45). 
Aghotor et 
al., 2010 
CTAM: 52/100 
 
Strengths: 
active control group.  
 
Weaknesses:  
underpowered; MCT 
and control group 
conditions not matched. 
RCT 
 
MCT n = 16 v active 
control group n = 14. 
 
 
 
PANSS 
No significant difference between groups on the change in positive 
PANSS, however an effect in favour of the MCT group was reported (d 
= 0.43, small to medium effect).  
 
JTC 
JTC assessed with BADE procedure (Moritz and Woodward, 2006). No 
significant difference between groups in pre-post scores of the JTC 
bias, although a small to medium effect favouring MCT was reported (d 
= 0.31). 
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Kumar et 
al., 2010 
CTAM: 44/100 
 
Strengths:  
TAU control.  
 
Weaknesses:  
small sample; no active 
control. 
 
RCT 
 
MCT n = 8 v TAU 
(pharmacological 
treatment and ward 
activities) n = 8. 
 
 
PANSS 
No significant difference between groups on the change in PANSS 
positive subscale score, although a medium to large effect in favour of 
the MCT group was reported (d = 0.68). 
 
 
Naughton 
et al., 2012 
CTAM: 29/100 
 
Strengths: 
waiting list control 
group.  
 
Weaknesses:  
chronological 
allocation. 
 
Naturalistic cohort study. 
 
MCT n = 11 (5 attended 
all sessions) v waiting list 
control group n = 8.  
 
 
PANSS  
No significant difference in the change scores between groups.  
 
 
Favrod et 
al., 2010 
CTAM: 21/100 
 
Strengths:  
used standardised 
measures.  
 
Weaknesses:  
no control; no blind 
assessment; no ITT 
analysis; no reporting of 
PANSS subscales. 
 
Uncontrolled pilot study 
 
MCT n = 24 (18 
analysed). 
 
 
PANSS  
Uncontrolled within group changes were reported. MCT within group 
scores decreased significantly on the delusion item (d = 1.04, large 
effect). No significant difference on the hallucinations item (d = 0.25).  
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Augmented Metacognitive Training 
 
Moritz et 
al., 2011b 
CTAM: 68/100 
 
Strengths:  
blinded randomisation; 
blinded assessment; 
ITT analysis.  
 
Weaknesses:  
idiosyncratic PANSS 
score.  
RCT 
 
MCT/MCT+ n = 24 v 
cognitive remediation 
program n = 24. 
PANSS 
Authors created a delusional subscale. Significant difference between 
groups on the PANSS delusion scores in favour of MCT/MCT+ (d = 
0.66, medium to large effect).  
 
JTC 
JTC assessed with computerised variant of the ‘Beads Task’ (Moritz et 
al., 2011a). Significant difference between groups in change scores of 
the percentage of participants showing the JTC bias in the MCT/MCT+ 
group relative to control group. A medium effect favouring MCT/MCT+ 
was reported (d = 0.58).  
 
 
Modules of Metacognitive Training 
 
Ross et al., 
2011 
CTAM: 51/100 
 
Strengths:  
active control group.  
 
Weaknesses: 
general 
psychopathology 
outcome not assessed; 
underpowered.  
RCT 
 
Reasoning Training 
Intervention (adapted 
from MCT) n = 17 v 
attention control 
condition n = 17. 
 
 
JTC  
JTC assessed with the ‘Beads Task’. Intervention effect was examined 
by estimating the proportional increase in beads drawn. Intervention 
significantly (p = 0.012) increased the number of beads drawn by 50% 
compared with the controls. 
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Lecardeur 
et al., 2009 
CTAM: 22/100 
 
Strengths: 
TAU control group.  
 
Weaknesses:  
small sample; no 
random allocation. 
Pseudo-randomised 
controlled trial. 
 
Mental State Attribution 
Therapy (MSAT) 
(included 2 sessions of 
MCT) n = 8 v Mental 
Flexibility Therapy (MFT) 
n = 8 v TAU n = 8. 
PANSS 
Significant difference between groups on the positive subscale. MFT 
obtained significantly lower scores than MSAT and TAU.  
 
 
Waller et 
al., 2011 
CTAM: 17/100 
 
Strengths:  
limitations 
acknowledged.  
 
Weaknesses:  
same individual 
conducted assessment 
and intervention; no 
control group; no 
blinded assessment; 
underpowered. 
A – B design 
 
Maudsley Review 
Training Program 
(includes one adapted 
MCT module) n = 14 (13 
completed). 
 
 
JTC 
JTC assessed with ‘Beads Task’. Uncontrolled within group changes 
were reported. No significant difference in number of beads requested 
following training within this uncontrolled group, although a small to 
medium effect was found (d = 0.30).  
 
CTAM: Clinical Trials Assessment Measure (Tarrier and Wykes, 2004). BADE: Bias Against Disconfirmatory Evidence procedure (Moritz and Woodward, 
2006). ITT: Intention to treat analysis. JTC: Jumping to Conclusions. M = mean. MCT: Metacognitive Training. MCT/MCT+: Metacognitive Training and 
Individualised Metacognitive Therapy. PANSS: Positive and Negative Syndrome Scale (Kay et al., 1987). RCT: Randomised Controlled Trial. TAU: Treatment 
as Usual. SD: Standard deviation. 
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3.4.1 Effect on positive symptoms 
Five studies assessed the effect of full MCT on the PANSS. Of these, three 
studies reported results on the positive subscale (Aghotor et al., 2010; 
Kumar et al., 2010; Naughton et al., 2012), one study did not differentiate 
results according to individual PANSS subscales (Moritz et al., 2011a), and 
Favrod et al. (2010) reported results on individual PANSS items. Moritz et al. 
(2011b) delivered augmented MCT, and reported an idiosyncratic 'delusion' 
score. Of the studies employing MCT modules, Lecardeur et al. (2009) used 
the PANSS to evaluate change, however, Ross et al. (2011) and Waller et al. 
(2011) employed it as a baseline measure only.  
 
On an individual level most studies did not find significant between group 
differences when MCT was compared to a control condition. Preliminary 
evidence suggests that full MCT exerted a small effect on positive 
symptoms, as assessed by the positive subscale of the PANSS, but that 
drawing on modules of MCT did not provide any additional benefit over and 
above treatment as usual. The additional provision of individual MCT was 
associated with the largest between group effect, which was in the medium 
to large range (Moritz et al., 2011b).  
 
 
3.4.1.1 Full MCT  
Moritz et al. (2011a) compared MCT to a treatment as usual (TAU) wait-list 
group in a study that obtained a ‘good’ CTAM score. Insufficient descriptive 
statistics were provided to report results specifically for the positive subscale. 
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The authors reported that there were no significant differences between 
groups on any of the PANSS subscales in terms of change scores, although 
small to medium between group effect sizes were reported (d < 0.38). It was 
not clear whether this effect favoured MCT or not, although favourable 
results for MCT were found on certain items of the Psychotic Symptom 
Rating Scales (PSYRATS) (Haddock et al., 1999). The study was 
methodologically robust in terms of employing a control group, blinded 
randomisation, and assessments being made blind to group allocation. The 
use of an active control group to control for non-MCT specific effects such as 
therapeutic contact would have improved this study further.  
 
Aghotor et al. (2010) conducted a pilot RCT, which obtained a ‘moderate’ 
score on the CTAM, and was designed to assess the efficacy of MCT versus 
an active control group. There was no significant difference between groups 
on the PANSS positive subscale change scores, although a greater 
attenuation of positive symptoms was noted in the MCT group (d = 0.43, 
small to medium effect). This pilot RCT was underpowered to detect 
significant change, and it is possible that the effect described could be due to 
the non-matched conditions of MCT versus active control group, the former 
being delivered with increased intensity on a twice-weekly basis compared to 
the once weekly active control group.  
 
Kumar et al. (2010) conducted a study of ‘moderate’ methodological quality 
in which patients were randomly allocated to MCT+TAU or TAU. There was a 
significant decrease in PANSS positive scores over time, however the group 
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x time interaction effect was not significant. Despite this, the effect size 
difference between the two groups was medium to large and favoured MCT 
(d = 0.68). One limitation to this study was the small sample. Additionally, 
although participants were randomised to group, there was no active control 
group to control for the non-specific effects arising from an increase in 
therapeutic contact.  
 
Naughton et al. (2012) explored the effects of MCT for patients with 
psychosis in a secure forensic psychiatric hospital. This study obtained a 
‘poor’ CTAM score. Participants were allocated to either MCT or a wait-list 
control group, although this was on a chronological rather than randomised 
basis. No significant difference was found between groups in the change 
scores of the PANSS positive subscale, although a small between group 
effect was found in favour of the control group (d = -0.20). The PANSS 
scores for both groups showed no significant change over time (MCT change 
score: M = 2.2, SD = 4.9; control group change score: M = 1.3, SD = 3.9). 
The MCT group had a baseline mean score of 11.4 (SD = 3.7) compared to 
the controls’ baseline mean score of 14.0 (SD = 6.3). One of the limitations to 
this study was the small sample size, which may lead to missing beneficial or 
adverse effects.  
 
Favrod et al. (2010) conducted an uncontrolled pilot study, which scored 
poorly on the CTAM. Twenty-four participants were allocated to MCT, 
however six were excluded from analysis. The authors only reported scores 
on individual items of the PANSS. For PANSS positive subscale items there 
  
 27 
was significant change on the ‘delusion’ item (d = 1.04, large effect), 
although no significant difference was found on the ‘hallucinations’ item (d = 
0.25, small effect). No explanation was given for particular items being 
reported instead of subscale scores. Results must be interpreted cautiously 
due to the absence of a control group, lack of intention to treat (ITT) analysis 
and non-blinded assessment. 
 
A preliminary meta-analysis was completed in order to systematically 
combine the results of studies. Studies that delivered full MCT and reported 
change on the PANSS positive subscale were included in the meta-analysis. 
These criteria were applied in an attempt to overcome some of the 
heterogeneity of studies included in the review. Three studies were included 
in the meta-analysis (Aghotor et al., 2010; Kumar et al., 2010; Naughton et 
al., 2012), which delivered full MCT to 35 participants. The meta-analysis 
was conducted using software provided by Cumming (2012). The combined 
effect size for these three studies was small (d = 0.29; 95% CI -0.18 – 0.77). 
However, there was no significant effect for MCT versus control as the 95% 
CI crossed zero. Figure 2 shows the forest plot for these studies. It is of 
interest that the study with the lowest CTAM rating (Naughton et al., 2012) 
found negative results pulling the overall effect size down. 
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Figure 2: Forest plot of studies using full MCT included in the meta-analysis. 
 
 
3.4.1.2 Augmented MCT  
Moritz et al. (2011b) examined whether a combination of MCT and individual 
Metacognitive Therapy (MCT/MCT+) exerted an additional effect over an 
active control group (cognitive remediation training). This study was rated 
‘good’ methodologically, as it employed random allocation of participants, 
blinded assessment and ITT analysis. However, the main outcome measure 
for psychopathology was a ‘delusional score’, composed of the sum of 
PANSS delusion items from the positive and general psychopathology 
subscales. Results on this idiosyncratic composite score must be interpreted 
cautiously as, although it could be argued that targeting change in delusional 
items is appropriate given the focus of MCT on delusions, there is no data on 
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the validity or reliability of this particular use of the measure. There was a 
significant difference between groups on the PANSS delusion scores, with a 
medium to large effect favouring MCT/MCT+ (d = 0.66). The authors also 
employed three algorithms to calculate positive syndrome scores, although it 
is difficult to compare results on these algorithms with other studies that 
reported the positive subscale of the PANSS. All three algorithms indicated 
medium to large effects in favour of MCT/MCT+ (d = 0.59; d = 0.66; d = 
0.77).  
 
 
3.4.1.3 Modules of MCT  
Lecardeur et al. (2009) investigated the impact of two cognitive remediation 
therapy (CRT) approaches on psychotic symptoms and cognitive complaints 
versus a TAU control group. This study scored poorly on the CTAM. The first 
CRT approach targeted mental state attribution (MSAT), with two of eight 
sessions taken from MCT, whilst the second targeted mental flexibility (MFT). 
The authors hypothesised that the effect of MSAT on psychotic symptoms 
would exceed that of MFT, however the contrary was found. A significant 
difference in PANSS positive subscale scores was reported between the 
three groups when baseline scores were entered as a covariate, with the 
MFT group (Estimated Mean EM = 11.62) obtaining significantly lower scores 
than the MSAT group (EM = 15.57) and the control group (EM = 15.32). 
There was no significant difference between MSAT and TAU. These results 
must be interpreted with caution because of the small sample sizes 
employed and pseudo-randomisation on the basis of availability. 
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3.4.2 Effect on JTC 
Five studies examined the effect of MCT on JTC (full MCT: Aghotor et al., 
2010; Moritz et al., 2011a; modules of MCT Ross et al., 2011; Waller et al., 
2011). Studies providing full MCT did not find any significant between group 
differences on the JTC bias or number of draws to decision, although small 
to medium effects were reported. Ross et al. (2011), using modules of MCT, 
specifically targeted JTC. Following training, although participants requested 
more information before making a decision (more draws), the numbers of 
participants with the JTC bias did not change. Augmented MCT delivered the 
most promising results (Moritz et al., 2011b). 
 
 
3.4.2.1 Full MCT 
Moritz et al. (2011a) assessed the effect of MCT on JTC using the ‘fish task’, 
a computerised and modified variation of the ‘Beads Task’.  There was no 
significant difference between groups in the number of draws to decision, 
however, the results indicated an effect in favour of the MCT group (d = 0.52, 
medium effect). In terms of the within group change, the MCT group were 
reported to become more cautious in their decision making behaviour across 
time (change M = 1.11), whereas the control group showed nearly no change 
(change M = 0.33). Similarly, there was no significant difference between 
groups when the JTC bias (defined as a decision after one fish) was 
examined, although a small to medium effect favouring MCT was reported (d 
= 0.45). Within group change showed that the rate of the JTC bias was 
halved in the MCT group (56% to 28%), whereas the decline in the control 
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group was smaller (50% to 40%).  
 
Aghotor et al. (2010) assessed the JTC bias with the BADE procedure 
(Moritz and Woodward, 2006). This computerised procedure presents 
participants with three consecutive and ambiguous pieces of information 
about a situation. After each presentation of information, participants rate the 
plausibility of different interpretations on a ten-point scale, and are asked 
whether they would decide upon one interpretation. A decision after one 
sentence is judged as JTC bias. No significant difference was found between 
groups in terms of pre-post scores of the JTC bias, although a small to 
medium effect favouring MCT was reported (d = 0.31).  
 
 
3.4.2.2 Augmented MCT 
Moritz et al. (2011b) examined the effect of augmented MCT on JTC. This 
was assessed using the same task as Moritz et al. (2011a), although the JTC 
bias was defined as a decision after one or two fish. There was a significant 
difference between groups in change scores of the percentage of 
participants showing the JTC bias in the MCT/MCT+ group relative to 
controls, and a medium effect favouring MCT/MCT+ was reported (d = 0.58). 
However, the difference between groups may be due to this addition of 
individual metacognitive therapy to MCT as normal.  
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3.4.2.3 Modules of MCT 
Ross et al. (2011) conducted a RCT that obtained a ‘moderate’ rating on the 
CTAM. Participants were allocated to a 45 minute Reasoning Training 
Intervention (involved three tasks, two adapted from MCT) or an attention 
control condition (completion of neuropsychological tests). The tasks 
targeted data gathering, generation and consideration of alternative ideas, 
and the use of confirmatory and disconfirmatory evidence. JTC was 
assessed on the ‘Beads Task’. The key variable was the number of beads 
drawn, with the JTC bias defined as requesting two or fewer beads. The 
effect of the intervention was evaluated by estimating the proportional 
increase in beads drawn (ratio of beads drawn in the intervention group over 
the number of beads drawn by controls). The intervention significantly 
increased the number of beads drawn by 50% compared to the control (point 
estimate of the ratio = 1.49, p = .012, 95% CI 1.09 – 2.03). However, the 
numbers of participants with the JTC bias remained consistent, revealing that 
the amount of improvement was dependent on the baseline measurement. 
The methodology of this study was strengthened by the use of an a-priori 
power calculation, the random allocation of participants and adequate 
description of interventions. However, it would have benefited from a more 
robust assessment process, for example, employing a rater blind to condition 
to evaluate outcome.  
 
Waller et al. (2011) examined the effect of the Maudsley Review Training 
Program (MRTP), which included an adapted MCT module. This study 
scored very poorly on the CTAM, with a significant weakness being the lack 
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of a control group. JTC was assessed with the ‘Beads Task’. The number of 
beads drawn before a decision was recorded, and the JTC bias was 
considered to be a decision after seeing two or fewer beads. There was no 
significant difference in the number of beads requested following training 
within the uncontrolled group, although a small to medium effect was found 
(d = 0.30). Participants classified as showing the JTC bias at baseline 
requested an additional mean of 1.17 (SD = 1.91) beads, whereas those 
without the bias requested an additional mean of 0.57 (SD = 1.21) beads. 
The results from this study must be cautiously interpreted as it lacked a 
control group, employed a small sample and was underpowered to detect 
change in key outcomes. 
 
 
 
4.  Discussion 
The purpose of this systematic review was to examine the evidence for the 
effectiveness of MCT for individuals with schizophrenia. The review 
highlighted sizeable variations in methodological quality across studies and 
substantial differences in how MCT was provided (e.g. full MCT, augmented 
MCT, or modules of MCT). These issues are considered in greater detail 
below in relation to the evidence for MCT.  
 
The methodological quality of studies varied significantly. The overall highest 
rated study provided augmented MCT (Moritz et al., 2011b), whilst only one 
of the studies providing full MCT achieved a ‘good’ CTAM score (Moritz et 
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al., 2011a). Of the studies using MCT modules, Ross et al. (2011) achieved 
the highest CTAM score, which was in the ‘moderate’ category. The areas of 
strength, for these studies and those achieving a ‘moderate’ score (full MCT: 
Aghotor et al., 2010; Kumar et al., 2010), lay in the random allocation of 
participants, the use of a control group (either TAU or an active control), and 
a more robust assessment process of the main outcome (e.g. independent 
assessors, assessment masked to treatment group allocation and/or the use 
of standardised assessments).  
 
The ratings of all studies, except Ross et al. (2011), were negatively 
impacted by the use of small samples or the lack of a-priori sample size 
calculations. For example, sample sizes ranged between 8 - 24 participants 
per group (Table 1). Moritz et al. (2011b) employed the largest sample, 
although this still fell short of that required to attract positive ratings on the 
CTAM. Ross et al. (2011) was the only study to report an a-priori sample size 
calculation, however the majority of studies were underpowered to detect 
change.  
 
‘Poor’ or ‘very poor’ ratings on the CTAM were received by the remaining 
studies (full MCT: Naughton et al., 2012; Favrod et al., 2010; modules of 
MCT: Lecardeur et al., 2009; Waller et al., 2011). In addition to inadequate 
sample sizes, these studies were weakened by the absence of an 
independent active control group, lack of randomisation, and weaknesses in 
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the assessment of the main outcome (e.g. lack of independent assessors, 
absence of blinded assessment).  
 
In relation to positive symptoms of schizophrenia as assessed by the positive 
subscale of the PANSS, studies that provided full MCT did not find significant 
differences between groups when MCT was compared to a control condition. 
This was the case across studies rated as ‘moderate’ or ‘good’, although 
there was evidence of small to medium (Aghotor et al., 2010; Moritz et al., 
2011a), and medium to large (Kumar et al., 2010) effect sizes in favour of 
MCT. In a preliminary meta-analysis of the most homogeneous studies, only 
a small effect was found, which did not reach significance. It was possible to 
include just three studies in the meta-analysis, which is a small number of 
studies, and the overall effect size reported in the meta-analysis was 
reduced by the inclusion of the Naughton et al. (2012) study. The Naughton 
et al. (2012) study was the least methodologically robust study included in 
the meta-analysis and the only one in this review to be conducted in a 
forensic setting. It was also the only study delivering full MCT to report 
negative results, and it may be that the aforementioned factors contributed to 
this. It attracted lower scores in the allocation and assessment areas of the 
CTAM. In order to obtain greater clarity regarding the effectiveness of full 
MCT, further methodologically robust studies are required.  
 
The additional provision of individual metacognitive therapy was associated 
with the largest between group effect, which fell in the medium to large range 
(Moritz et al., 2011b). In contrast, Lecardeur et al. (2009) found that MSAT 
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(which employed modules of MCT) was less effective than MFT (an 
intervention targeting mental flexibility), which was contrary to the 
hypothesised direction. This may illustrate the importance of providing full 
MCT, rather than drawing upon modules of MCT, although this would require 
further replication.  
   
The effect of MCT on the JTC reasoning error was explored by five studies. 
Full MCT studies, rated ‘moderate’ or ‘good’ methodologically, did not find 
any significant differences between MCT and control groups in the number of 
draws to decision or the JTC bias, although small to medium effects were 
reported (Aghotor et al., 2010; Moritz et al., 2011a). Of the studies that 
provided modules of MCT, Ross et al. (2011) reported a significant increase 
in the amount of information that participants requested before making a 
decision. However, despite specifically targeting JTC, there was no change 
in the number of participants with the JTC bias after intervention. The Ross 
et al. (2011) study did not explore outcome on the PANSS, therefore, it is 
unknown whether this intervention would have led to a general improvement 
in positive symptoms. When augmented MCT was provided, a significant 
difference between groups was found in the percentage of participants 
showing a JTC bias (Moritz et al., 2011b). These results indicate that an 
individually tailored and intensive intervention, such as augmented MCT, 
may be required for those individuals who show the severest form of the JTC 
reasoning error (i.e. meet the criteria for JTC bias).  Pre-screening JTC 
reasoning error severity, for example using the Beads Task (Garety et al., 
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1991) to determine whether a JTC bias (decision after a draw of two or fewer 
beads) is evident, may be helpful in assessing suitability for augmented MCT 
rather than full MCT. 
 
There was significant variation in the use of outcome measures across 
studies. Despite the PANSS being the most frequently reported measure of 
psychopathology, the manner in which it was reported varied significantly. 
For example, results on individual PANSS items (Favrod et al., 2010), 
subscales (Aghotor et al., 2011; Lecardeur et al., 2009; Kumar et al., 2010; 
Moritz et al., 2011b; Naughton et al., 2012) and idiosyncratic composite 
scores (Moritz et al., 2011b) were reported. This restricted the number of 
studies that could be directly compared with one another. It may also 
introduce bias into the literature if items are selectively reported without a 
justification being provided (Favrod et al., 2010) or if a subscore is developed 
that has the potential to preferentially assess one intervention over another 
(Moritz et al., 2011b). As a minimum, results should be reported on the 
positive subscale to allow comparison between studies.   
 
MCT aims to target a range of social cognitive biases, however, only five 
studies considered biases, with outcome only assessed in relation to JTC 
(Aghotor et al., 2010; Moritz et al., 2011a; Moritz et al., 2011b; Ross et al., 
2011; Waller et al., 2011). The JTC bias is well studied in psychosis, 
however, none of the studies justified why this bias was preferentially 
assessed against others for which standardised measures are also available. 
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This limits the ability to compare the efficacy of MCT to other social cognitive 
interventions (Fizdon and Reddy, 2012). Across studies there was variation 
in how JTC was assessed and the JTC bias determined. Ross et al. (2011) 
and Waller et al. (2011) employed the ‘Beads Task’ (Garety et al., 1991). The 
remaining studies employed different measures, although each argued for 
similarity to the ‘Beads Task’. Aghotor et al. (2010) used the BADE 
procedure, and reported it as a valid measure of JTC because it maps on to 
the same JTC parameter as that of the ‘Beads Task’. Moritz et al. (2011a) 
and Moritz et al. (2011b) employed a computerised variant of the ‘Beads 
Task’. They argued that the measure provided similar results to the original 
task, however they each employed different cut-offs to determine the JTC 
bias. The ability to compare between studies would have been improved by 
the use of the same measure.  
 
 
4.1 Limitations  
There was significant heterogeneity across studies in how MCT was 
delivered, assessed and reported, which restricted the ability to compare 
studies and limited the studies that could be included in the meta-analysis. It 
is possible that this heterogeneity reflects the early stage of research within 
the area. The meta-analysis was conducted in order to try to overcome some 
of the heterogeneity of studies included in the review by combining evidence 
across the most similar studies. However, the results should be considered 
as preliminary and cautiously interpreted as a small number of studies were 
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included. The meta-analysis could be usefully revisited following the 
publication of additional studies examining MCT.  
 
Mortimer et al. (2007) proposed that treatment studies should consider 
outcome as multi-faceted, and that assessment of outcome should focus not 
only on symptom rating scales, but also encompass meaningful appraisal of 
cognition, personal, and social functioning. A limitation of this review is 
therefore the focus on one measure of psychopathology, the PANSS, 
although this reflects the reviewed studies reliance upon symptom rating 
scales to assess outcome. Future studies may wish to address this limitation 
by employing a broader range of measures to assess treatment outcome. 
The PSYRATS (Haddock et al., 1999) was employed in some studies, and 
more detailed comparison of the effect of MCT on the PSYRATS may be 
usefully included in any future reviews. The focus of this review was on 
examining the evidence for MCT, and as part of this, it would have been of 
interest to explore the subjective appraisal of MCT. This may be an area for 
consideration in subsequent reviews.  
 
 
4.2 Recommendations 
Studies could be improved by the use of larger sample sizes. Assuming a 
medium effect size (d = 0.5), an alpha level of .05 and power of 0.80, an a-
priori sample size estimation conducted in G*Power3 reveals that 64 
participants per group would be required for a two-tailed t-test between two 
independent groups (Faul et al., 2007). Such sample sizes could be targeted 
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in future by the development of multi-centre trials. Methodological quality 
could be improved by the use of active control groups and the random 
allocation of participants to groups. The addition of individual metacognitive 
therapy warrants further exploration as results published by Moritz et al. 
(2011b) appear promising. An interesting avenue for research may lie in 
examining the effectiveness of augmented MCT versus full MCT or other 
social cognitive interventions, and in exploring whether any improvement is 
maintained at follow-up. 
 
 
4.3 Conclusion 
In response to limitations associated with the use of antipsychotic medication 
in the treatment of schizophrenia, and in growing recognition of the 
importance of psychological processes in psychosis, psychological therapies, 
psychosocial and social cognitive interventions have been the subject of 
increased research activity. MCT is one such intervention, however, further 
methodologically robust studies are required before it can be firmly 
established whether or not MCT effectively reduces positive symptoms or 
improves reasoning in individuals with schizophrenia. As the literature stands 
at present, there is emerging evidence that MCT can reduce positive 
symptoms, however, a preliminary meta-analysis was not able to provide 
clear support for this. A similar picture is also emerging in terms of the effect 
MCT has on JTC, although this appears to be in the order of a small to 
medium effect. The additional provision of individual metacognitive therapy 
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appears promising in terms of its ability to improve positive symptoms and 
the JTC bias (Moritz et al., 2011b).  
 
If additional methodologically robust studies provide further evidence in 
support of MCT, then MCT has the potential to inform clinical practice in 
several ways. MCT could be implemented within in-patient settings in a 
complementary role to standard treatment programs for individuals with 
schizophrenia. MCT, delivered as a group intervention, may be more feasibly 
implemented within such settings as it is less clinician intensive than 
individualised approaches. As such, it may provide a first step in raising 
awareness of the social cognitive biases that are thought to underpin the 
formation and maintenance of psychotic symptoms (Moritz et al., 2005; 
Moritz et al., 2011b). The additional provision of individualised metacognitive 
therapy may be more suitable for individuals not wishing to engage in a 
group intervention, or for individuals who do not benefit from such an 
intervention. However, as described above, further research is required 
before MCT can be confidently incorporated into standard treatment 
programs for individuals with schizophrenia.   
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Plain English Summary  
 
 
 
Theory of Mind in individuals with paranoid schizophrenia. 
 
 
 
Background 
Theory of mind (ToM) refers to the ability to represent one’s own and other 
person’s thoughts and beliefs. It is impaired in individuals with schizophrenia 
in comparison to healthy participants. However, the nature of this impairment 
in individuals with paranoid symptoms is unclear, as some studies have 
found evidence of impairment and others have not (Brüne, 2005).  
 
Individuals with schizophrenia tend to misperceive emotions, make inflated 
estimates of the likelihood of future threatening events and pay more 
attention to threatening stimuli (Kohler et al., 2010; Phillips et al., 2000). ToM 
can be assessed using tasks that require mental state (i.e. what someone 
might be thinking or believing) to be deduced from cues (such as eye 
expressions) or from scenarios (illustrate characters cooperating or deceiving 
others). These tasks include different emotional content, and it is possible 
that this might also affect performance given the above tendency to 
misperceive emotions and attend to threat. 
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Aim and questions 
The aim was to examine whether ToM ability in individuals with paranoid 
schizophrenia varied according to the emotional content of items within ToM 
tasks. It addressed three questions:  
 
1. Is there a difference in ToM ability between individuals with 
paranoid schizophrenia and healthy participants? 
  
2. Is any difference between groups affected by the emotional 
content of items within the ToM tasks?  
 
3. Are individuals with paranoid schizophrenia more accurate on 
threat items within ToM tasks?  
 
 
 
Methods 
All participants were given written information about the study, and informed 
consent was obtained. The patient group (n = 8) was recruited from in-patient 
rehabilitation wards and community outreach teams. The inclusion criteria 
were: 
 Diagnosis of paranoid schizophrenia 
 Able to provide informed consent 
 16 – 65 years old 
 English as first language 
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 No changes in medication  
The group of healthy participants (n = 8) was recruited from a single GP 
practice. They met the above inclusion criteria, except that they were 
required to have no diagnosed mental health problems. The exclusion 
criteria applied to both groups included:  
 History of traumatic brain injury 
 Learning disability 
 Active substance dependence 
Participants completed two ToM tasks and a measure to estimate pre-morbid 
intellectual functioning.  
 
 
 
Main findings and conclusions 
The group of healthy participants performed more accurately than the patient 
group on ToM tasks, providing further evidence for ToM impairment in 
individuals with paranoid schizophrenia. On one task, there was a trend 
towards ToM ability in individuals with paranoid schizophrenia being affected 
by the emotional content of items. However, this was not in the anticipated 
direction of those with paranoid schizophrenia more accurately recognising 
threat emotions. No evidence was found on the second ToM task for the 
emotional content of the task affecting accuracy. Limitations to the study 
included small samples that were unmatched for pre-morbid intellectual 
functioning.  
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Abstract 
Individuals with schizophrenia show deficits in theory of mind (ToM), 
however the nature of these deficits in individuals with paranoid symptoms is 
unclear. This study examined whether ToM ability in individuals with 
paranoid schizophrenia varied according to the emotional valence of items 
within ToM tasks. Eight participants with a diagnosis of paranoid 
schizophrenia (patient group) and eight healthy controls completed two ToM 
tasks, the revised Eyes Test and a newly developed mental state reasoning 
task (New ToM Measure). Controls were significantly more accurate than the 
patient group on both tasks (revised Eyes Test: t (14) = 4.48, p = .001, d = 
2.24, New ToM Measure: t (14) = 3.63, p = .003, d = 1.82). There was 
evidence of a trend for a mediating role of emotional valence in the patient 
group on the revised Eyes Test, although contrary to the study’s hypothesis, 
patients were more accurate on positive items than threat items (t (7) = 2.19, 
p = .07, d = 1.01). There was no evidence of a mediating role of emotional 
valence on the New ToM Measure. This study provides further evidence of 
ToM deficits in individuals with schizophrenia. The mixed evidence for the 
mediating role of emotional valence is discussed in relation to existing 
literature and the study’s limitations.   
 
 
Keywords: theory of mind, paranoid schizophrenia, revised Eyes Test 
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1. Introduction 
1.1 Theory of mind and schizophrenia 
Theory of mind (ToM) refers to the cognitive capacity to represent one’s own 
and other person’s mental states, and allows an individual to attribute 
thoughts, beliefs, intentions or feelings to others (Brüne, 2005, Scherzer et 
al., 2012). A substantial body of evidence demonstrates that this ability is 
impaired in individuals with schizophrenia versus healthy controls, even 
when the heterogeneity of tasks employed to assess ToM is accounted for 
(Bora et al., 2009). Whilst ToM deficits in schizophrenia are well established, 
contradictory results have been reported regarding ToM impairment in 
patients in the acute phase of schizophrenia and after remission, in relation 
to IQ, executive function and memory abilities (Bora et al., 2009). The nature 
of ToM deficits specifically in patients with paranoid symptoms is also 
unclear, as some studies have reported impaired ToM capacity, whilst others 
have failed to confirm this link (Brüne, 2005). 
 
Several different paradigms have been used to assess ToM in 
schizophrenia. These can be usefully grouped according to mental state 
reasoning tasks (e.g. assessing false belief, deception and intention 
understanding, and pragmatic speech comprehension), mental state 
decoding tasks (e.g. inferring mental states from cues, such as eye 
expressions), and real-world tasks (e.g. assessing structured interviews) 
(Bell et al., 2010). It is possible that the inconsistent results in individuals with 
paranoid symptoms could be related to the nature of these tasks. Support for 
this was reported by Bora et al. (2009) in a meta-analysis where tasks were 
  
 54 
grouped according to whether false belief was assessed using story 
comprehension or sequencing. The authors found that the distributions of 
effect sizes were much less heterogeneous for individual tasks compared to 
combined tasks and total ToM score.  
 
 
1.2 ToM and paranoid symptoms 
A number of cognitive processes are implicated in paranoid symptoms, 
including disruptions at the neurocognitive and social-cognitive levels, arising 
from deficits (e.g. poor attention) and/or biases (e.g. a self-serving and 
personalising bias, and information-processing biases) (Peer et al., 2004). 
Bentall et al. (2009) conducted an analysis of a range of psychological 
mechanisms to determine the cognitive and affective processes associated 
with paranoia, and reported paranoid delusions to be associated with a 
combination of pessimistic thinking style (low self-esteem, pessimistic 
explanatory style, and negative emotion) and impaired cognitive performance 
(executive functioning, tendency to jump to conclusions), and ability to 
reason about the mental states of others.  
 
Individuals with schizophrenia are less accurate, relative to healthy controls, 
in recognising facial emotions (Kohler et al., 2010). Interestingly, individuals 
with schizophrenia have been reported as over-attributing disgusted 
expressions and under-attributing happy expressions to neutral cues (Kohler 
et al., 2003),  whilst a tendency to misperceive emotions (including happy, 
sad, fear and surprise emotions) as disgust rather than anger has been 
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reported in individuals with paranoid symptoms (Peer et al., 2004). This has 
been assessed using stimuli that consist of facial expressions that represent 
a range of emotions including happy, sad, angry, disgust or neutral (Kohler et 
al., 2003; Peer et al., 2004).  
 
The 'Reading the Mind in the Eyes' task (Baron-Cohen et al., 2001), which is 
similar to the paradigm described above, is contended to be an advanced 
ToM test because the stimuli consist of only pictures of the eyes (Bell et al., 
2010). It measures the ability to identify cognitive emotions that require 
inferences about others' beliefs or intentions (e.g. being embarrassed or 
pensive). Cognitive emotions can be distinguished from 'basic emotions', 
which do not require this kind of inference (e.g. happy or disgusted) (Craig et 
al., 2004). Craig et al. (2004) reported a poor performance on the Eyes Test 
by individuals with a diagnosis of paranoid schizophrenia. However, no 
information was provided regarding whether performance varied according to 
the direction of emotion (e.g. positive, negative, and neutral) included in the 
Eyes task.  
 
In addition to a tendency to misperceive emotions, paranoid patients appear 
to make inflated estimates of the likelihood of future threatening events 
(Bentall et al., 2009), and demonstrate heightened attention to threatening 
stimuli (Bentall and Kaney, 1989; cited in Phillips et al., 2000). For example, 
in an emotional Stroop test, a significantly greater amount of time was 
required for paranoid individuals to name the print colours of threatening 
versus depressive and neutral words (Bentall and Kaney, 1989; cited in 
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Phillips et al., 2000). Many of the mental state reasoning ToM tasks involve 
the deception of characters. For example, Frith and Corcoran's (1996) False 
Belief and Deception Story (FBDS) task, commonly employed in 
schizophrenia research, involves six ToM stories (first-order and second-
order) being read to subjects, of which four involve a character being 
deceived and centre around a theme of stealing. Performance on ToM tasks 
are not generally considered in relation to the specific emotional content of 
the task, and it is unclear whether this could be a factor affecting an 
individual's performance.  
 
Abdel-Hamid et al. (2009) used a five-factor model of the Positive and 
Negative Syndrome Scale to explore the association of symptom clusters 
and individual symptoms with ToM ability in schizophrenia. Contrary to their 
expectations, the authors reported that there was no significant association 
of positive symptoms and impaired ToM. Unexpectedly, there was a 
significant interaction of impaired ToM with items included in the 'emotional 
distress factor'. For example there were significant inverse interactions, all 
largely independent of IQ or executive functioning, between ToM deficit and 
the items ‘tension’ and ‘depression’, with decreasing symptom severity on 
these items associated with better ToM performance. A strong positive 
interaction between ToM and ‘guilt’ was also found, with participants 
exhibiting increasing symptom severity achieving greater accuracy on the 
ToM task. It is possible that several methodological factors could have 
contributed to these results, including that there was a relatively 
heterogeneous clinical sample that included a range of both positive and 
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negative symptoms. In addition, a single measure of ToM was employed.  
 
The ToM task employed by Abdel-Hamid et al. (2009) was Brüne's (2003) 
Picture Sequencing Task, which comprises picture stories with questions to 
assess a range of false beliefs, reciprocity, deception and cheating detection 
(Bell et al., 2010). It is possible that the differing emotional content (e.g. 
neutral stories and stories involving deception) within this ToM task might 
have affected performance given the evidence regarding the tendency of 
individuals with paranoid schizophrenia to attend to threatening stimuli and 
misperceive emotions (Bentall et al., 2009; Peer et al., 2004).  
 
 
1.3 Theoretical frameworks 
A number of different theoretical frameworks have been proposed in order to 
account for ToM deficits in schizophrenia. For example, Frith (1992) 
proposed that positive and negative symptoms in schizophrenia can be 
accounted for by abnormalities in brain function and circuitry that give rise to 
the individual's failure to monitor their own and other persons' mental states 
and behaviour (Brüne, 2005). In contrast, Hardy-Baylé et al. (2003), has 
proposed that ToM impairments in schizophrenia are primarily related to an 
executive or planning deficit. Evidence in support of Frith's (1992) and Hardy-
Baylé et al.'s (2003) conceptualisations has been mixed (Brüne, 2005; Abdel-
Hamid et al., 2009), for example, contrary to Frith's prediction, individuals in 
remission have also shown ToM impairments relative to non-clinical controls 
(Bora et al., 2009). This suggests that ToM deficits may be 'trait' rather than 
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'state' impairments that is, enduring characteristics of the disorder versus 
being linked to the presence of symptoms (Bora et al., 2009). 
 
An alternative approach to that of Frith (1992) and Hardy-Baylé has been 
outlined by Gumley (2010). Gumley (2010) has proposed that ToM 
impairments are rooted in compromised normative developmental pathways, 
characterised by negative interpersonal experiences (e.g. lack of secure 
base and/or the presence of relational trauma and loss during childhood and 
adolescence), which reduce an individual's ability to develop skill in 
representing one's own and other persons' mental states. Gumley (2010) 
observes that in schizophrenia, affect regulation strategies tend towards 
minimising affect and affect laden memories, and that this in combination 
with ToM deficits may contribute to understanding the development and 
maintenance of negative symptoms, disorganisation and vulnerability to 
relapse.  
 
The theoretical frameworks proposed by Frith (1992) and Hardy-Baylé et al. 
(2003) are limited in their ability to account for the direction of the above 
findings, for example the tendency to misperceive a range of emotions as 
disgust. Clarifying whether ToM ability varies according to the emotional 
content of the specific items of a ToM task could contribute to explaining the 
inconsistencies that have been reported in the literature, and also contribute 
to a greater understanding of the theoretical frameworks that attempt to 
account for ToM impairments in individuals with schizophrenia.  
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1.4 Aim 
To examine whether ToM ability in individuals with paranoid schizophrenia 
varies according to the emotional valence of items within ToM tasks.  
 
 
1.4.1 Hypotheses 
The research will address several hypotheses including: 
 There will be a significant difference in ToM ability in individuals with 
paranoid schizophrenia compared to controls.  
 There will be a significant difference in ToM ability in individuals with 
paranoid schizophrenia compared to controls, but this will be 
mediated by the emotional valence of items within the ToM tasks.  
 Individuals with paranoid schizophrenia will show greater accuracy on 
items within ToM tasks that include an element of threat versus items 
that have no threat. 
Additionally, the research will explore the types of errors made by 
participants.  
 
 
 
2. Methods 
2.1 Participants 
2.1.1 Inclusion and exclusion criteria 
The patient group was recruited from NHS Greater Glasgow and Clyde 
psychiatric rehabilitation wards and rehabilitation outreach teams. The 
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inclusion criteria for the patient group were: a diagnosis of paranoid 
schizophrenia; ability to provide informed consent; between 16 and 65 years 
of age; English as a first language; and, no changes in medication during the 
study period. The exclusion criteria were a history of traumatic brain injury, 
learning disability or active substance dependence. The control group was 
recruited from patients attending appointments at a single GP practice in 
Glasgow. The inclusion criteria for the control group were similar, except that 
they were required to have no diagnosed mental health problems. The same 
exclusion criteria were applied to the control group.  
 
 
2.2 Measures 
The Brief Psychiatric Rating Scale (BPRS) (Overall and Gorham, 1962) was 
employed to assess general psychopathology in the patient group. The 
psychometric properties of the BPRS have been reported as adequate 
(Kopelowicz et al., 2008). All participants completed the Wechsler Test of 
Adult Reading (Wechsler, 2001), which provided an estimate of pre-morbid 
intellectual functioning.  
 
Two tasks were employed to assess ToM. The first was the revised Eyes 
Test (referred to as the Eyes Test) (Baron-Cohen et al., 2001) available 
online from the Autism Research Centre (http://www.autismresearc 
hcentre.com/arc_tests). The task involves the attribution of the relevant 
mental state from photographs of the eye region of faces by making a forced 
choice between four words (the target word and three distracters) for a total 
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of 36 items. It has good discriminant validity, and has consistently shown that 
participants with schizophrenia perform worse than controls (Bell et al., 
2010). Outcome on the full Eyes Test was total score calculated as a 
percentage. A pilot was conducted to identify items for the positive condition 
and threat condition using a similar procedure to Harkness et al. (2005) 
(Appendix 2.0). Twelve threat items and eight positive items were identified. 
The maximum achievable score was twelve for threat items and eight for 
positive items. Percentage accuracy scores were used to assess 
performance and to allow comparison between valence conditions.  
 
The second ToM task was developed as part of this study and was based on 
the Picture Sequencing Task (PST) (Brüne, 2003), which was kindly made 
available for use by its author. An initial measure was piloted on a small 
convenience sample (Appendix 2.1). The New ToM Measure consists of a 
neutral practice item, three scenarios employing a threatening theme, and 
three scenarios employing a positive theme, each represented by four 
photographs. The task involves a sequencing component and questions to 
assess understanding of first-order and second-order belief and false belief; 
third-order false belief, reciprocity, deception and cheating detection (i.e. one 
character’s detection of another character’s intention to deceive them). The 
total score that can be achieved on the test is 60 and overall scores on the 
measure were calculated as a percentage. Percentage accuracy scores 
were used to assess performance according to valence conditions. An 
example item is provided in Appendix 2.2, and the manual in Appendix 2.3.  
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2.2.1  Recruitment Procedure 
Participants in the patient group were referred to the study by members of 
their healthcare team. A psychiatrist applied inclusion and exclusion criteria 
and determined capacity to consent. Participants in the control group opted-
in to the study after reading the participant information sheet at their GP 
Practice. Written informed consent was obtained from each participant.  
 
 
2.2.2 Research Procedure 
Study tasks were administered in a single interview of approximately 30 
minutes duration. The Eyes Test was administered in paper format, and in 
accordance with the procedures outlined in the manual (Baron-Cohen et al., 
2001). For each set of eyes, participants were asked to select which word 
best described what the person in the picture was thinking or feeling.  
 
The New ToM Measure was administered in a similar manner to the PST 
(Brüne, 2003). The administration process is described in the manual 
(Appendix 2.3). Briefly, participants were requested to place four 
photographs in a logical sequence, and then asked a series of questions in 
the form “what does X believe Y intended to do?”. The RAND function in 
EXCEL Microsoft Office 2007 was used to randomise the order of 
photograph presentation within each item and to counterbalance the order 
with which the three threat items or the three positive items were presented.  
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The WTAR (Wechsler, 2001) was administered to all participants in 
accordance with manual instructions. It is composed of 50 words with 
irregular pronunciations that participants are requested to read aloud. The 
BPRS was completed in consultation with each patient’s named nurse in a 
separate meeting.   
 
 
2.3 Design and sample size calculation 
A mixed design was employed with Group as between-subjects (patient and 
control) and emotional valence as within-subjects (positive and threat). 
Accuracy, defined as the percentage of items where the participant provides 
a correct response, was the dependent variable. A sample size calculation 
was conducted for the main comparison of interest, whether there is a 
significant difference between accuracy on positive items and accuracy on 
threat items in individuals with a diagnosis of paranoid schizophrenia. 
Harkness et al. (2005), in a study of dysphoric college students, reported 
descriptive statistics for positive and negative items in the Eyes Test. These 
statistics were used to calculate the effect size for the difference in scores 
between positive and negative items (Cohen’s d = 0.74). A sample size 
calculation for an ANOVA (repeated measures, within-between interaction) 
with an effect of d = 0.70, α of .05 and power of 0.80, revealed that a total 
sample of 24 was required (Faul et al., 2007).  
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2.4 Ethics   
NHS Greater Glasgow and Clyde West of Scotland Research Ethics Service 
(WoSRES) confirmed favourable ethical opinion on 17th April 2012 (Appendix 
2.4), and NHS Greater Glasgow and Clyde Research and Development 
(NHS R&D) approved the project on 18th January 2013 (Appendix 2.5). A 
major amendment to facilitate recruitment to the control group was approved 
by WoSRES on 3rd June 2013 (Appendix 2.6) and by NHS R&D on 7th June 
2013 (Appendix 2.7).  
 
 
 
3. Results 
3.1 Analyses 
Assumptions of normality and homogeneity of variance were met, therefore 
parametric tests were employed. Analyses included all participants unless 
otherwise specified. Effect sizes were calculated using an online effect size 
calculator (Becker, 2000) or formula 4 provided by Thalheimer and Cook 
(2002). They are reported as Cohen’s d, and have been interpreted as small 
if d = 0.2, medium if d = 0.5 and large if d = 0.8 (Cohen, 1988). 
 
 
3.2 Participants 
3.2.1 Sample  
Seventeen participants were referred to the patient group, and of these nine 
declined to participate. The eight participants in the control group opted-in to 
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the study, and it was not possible to monitor the number that declined to 
participate. Participant demographics are reported in Table 1. The mean age 
of participants was 40.13 years (SD = 11.15). There was no significant 
difference between groups in age (t (14) = -1.39, p = .19) or gender (Fisher’s 
Exact Test, p = .72). However, controls scored significantly higher on the 
WTAR than patients (t (13) = 2.78, p = .021). In the patient group, the mean 
BPRS score was 46.38 (SD = 16.90).  
 
Table 1: Participant Demographics. 
 Control (n = 8) Patient (n = 8) 
Gender 6 Female, 2 Male 2 Female, 6 Male 
Age M = 36.38 (SD = 13.63) M = 43.88 (SD = 6.98) 
WTAR* M = 104.86 (SD = 12.19) M = 87.25 (SD =  12.33) 
BPRS ** M = 46.38 (SD = 16.90) 
*p < .05, n = 15, M = mean; SD = standard deviation; WTAR = Wechsler Test of Adult 
Reading (Wechsler, 2001); BPRS = Brief Psychiatric Rating Scale (Overall and Gorham 
1962); **patient group only. 
 
 
3.3 Theory of Mind tasks 
3.3.1 Overall accuracy 
Overall accuracy on the two ToM tasks was examined separately for each 
task (Table 2). The dependent variable was the total expressed as a 
percentage of the maximum achievable score on each task. There was a 
significant difference between groups in overall accuracy on the Eyes Test (t 
(14) = 4.48, p = .001), with the control group (M = 76.39, SD = 10.50) more 
accurately attributing the mental state of a person than the patient group (M 
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= 49.65, SD = 13.23) (d = 2.24, large effect). A similar result was found for 
the New ToM Measure, with the control group (M = 76.67, SD = 21.44) 
achieving greater accuracy on the task than the patient group (M = 44.79, 
SD = 12.55) (t (14) = 3.63, p = .003, d =1.82, large effect). Table 2 provides 
mean accuracy scores.  
 
Table 2: Means, standard errors and 95% Confidence Intervals for overall 
accuracy on the Eyes Test and New ToM Measure. 
 95 % Confidence Interval 
Task Group Mean Standard 
Error 
Lower Bound Upper Bound 
Eyes 
Test 
Control  76.39 3.71 67.61 85.17 
Patient 49.65 4.68 38.59 60.72 
New ToM 
Measure 
Control 76.67 7.58 58.75 94.59 
Patient 44.79 4.44 34.30 55.28 
 
 
 
3.3.2 Performance according to emotional valence 
3.3.2.1 Eyes Test 
An ANOVA with Group (Control or Patient) as a between-factor and Valence 
(Threat or Positive) as a within-factor was conducted. The dependent 
variable was accuracy, defined as the percentage of items for which a 
correct response was given. Table 3 shows the mean accuracy scores for 
controls and patients according to the valence of items on the Eyes Test.  
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Table 3: Means, standard errors and 95% Confidence Intervals for accuracy 
on the Eyes Test according to valence.  
 95 % Confidence Interval 
Group Valence Mean Standard 
Error 
Lower Bound Upper Bound 
Control  Positive 75.00 3.34 67.84 82.17 
 Threat 74.99 7.26 59.44 90.56 
Patient  Positive 62.50 3.34 55.34 69.67 
 Threat 42.70 7.26 27.14 58.27 
 
There was a significant main effect of group (F (1, 14) = 12.46, p = .003), 
with participants in the control group (M = 74.99, SE = 4.49, 95% CI 65.38 – 
84.62) performing with greater accuracy than participants in the patient group 
(M = 52.60, SE = 4.49, 95% CI 42.98 – 62.23) (d = 1.89, large effect). A 
marginally non-significant difference was found for the main effect of Valence 
(F (1, 14) = 4.16, p = .06), although a medium sized effect was calculated (d 
= 0.55). The mean accuracy for positive items was 68.75 (SE = 2.36, 95% CI 
63.68 – 73.82) compared with a mean accuracy for threat items of 58.85 (SE 
= 5.13, 95% CI 47.85 – 69.86). The interaction effect for Group x Valence 
was similarly marginally non-significant (F (1, 14) = 4.16, p = .06). Figure 1 
illustrates that accuracy on positive items and accuracy on threat items was 
essentially unchanged in the control group (M difference = .00, SD = 9.96), 
whilst in comparison the mean difference for the patient group was 19.80 
(SD = 25.57). The difference in patients’ accuracy comparing positive to 
threat items indicated a trend that did not quite meet significance (t (7) = 
2.19, p = .07), although a large effect was found (d = 1.01). 
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Figure 1: Mean accuracy on the Eyes Test of controls and patients according 
to valence. The control group is illustrated with a dashed line. Error bars 
represent 95% confidence intervals.  
 
 
3.3.2.2 New ToM Measure 
An ANOVA with Group (Control or Patient) as a between-factor and Valence 
(Threat or Positive) as a within-factor was conducted. The dependent 
variable was accuracy, defined as the percentage of items for which a 
correct response was given. Table 4 provides mean accuracy scores on the 
New ToM Measure for controls and patients according to valence.  
 
  
 69 
Table 4: Means, standard errors and 95% Confidence Intervals for the New 
ToM Measure.  
 95 % Confidence Interval 
Group Valence Mean Standard 
Error 
Lower Bound Upper Bound 
Control  Positive 79.17 6.89 64.40 93.94 
 Threat 76.04 7.23 60.53 91.56 
Patient  Positive 45.83 6.89 31.06 60.60 
 Threat 47.92 7.23 32.40 63.43 
 
There was a significant main effect of Group (F (1, 14) = 12.14, p = .004), 
with participants in the control group (M = 77.61, SE = 6.24, 95% CI 64.23 – 
90.98) performing with greater accuracy than the patient group (M = 46.87, 
SE = 6.24, 95% CI 33.50 – 60.25).  A large effect was calculated that 
favoured the control group (d = 1.32). However, no significant difference was 
found for the main effect of Valence (F (1, 14) = .01, p = .91) (Positive M = 
62.50, SE = 4.87, 95% CI 52.06 – 72.94; Threat M = 61.98, SE = 5.11, 95% 
CI = 51.01 – 72.95) (d = 0.03) or the Group x Valence interaction (F (1, 14) = 
.31, p = .59). Figure 2 illustrates the mean accuracy of control and patient 
groups on positive and threat items.  
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Figure 2: Mean accuracy on the New ToM Measure of controls and patients 
according to valence. The control group is illustrated with a dashed line. 
Error bars represent 95% confidence intervals. 
 
 
3.3.3 Errors 
3.3.3.1 Errors on Eyes Test 
Differences between groups in the pattern of errors made were examined. 
The ability to do this was somewhat confounded in that the valence of 
distracter choices varied. Sometimes, the distracter choices for an item 
included one that was in the same valence as the target (e.g. the threat item 
‘distrustful’ had two distracters that matched the target valence, ‘aghast’ and 
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‘terrified’, and a neutral distracter ‘impatient’), whilst for other items none of 
the distracters matched the target valence (e.g. the positive item ‘reflective’ 
had one neutral distracter, ‘impatient’, and two threat distracters, ‘aghast’ and 
‘irritated’). Given this confound, a statistical examination of differences 
between groups in the pattern of errors was not conducted, and the results 
below are descriptive only. 
 
Distracter items were classified according to whether they were of ‘threat’, 
‘neutral’ or ‘positive’ valence (Appendix 2.8). Participants’ errors were 
categorised according to the valence of the target item, and whether the 
distracter item was a ‘threat’, ‘neutral’ or ‘positive’ valence. The contingency 
table of participants’ errors is contained in Table 5. Similar errors were made 
in both groups overall: when errors were made on positive items, neutral 
valence distracters were most frequently selected, whereas when errors 
were made on threat target items, threat valence distracters were most 
frequently selected. However, when participants made an error on a positive 
item, patients made more threat attributions compared to controls.  
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Table 5: Contingency table of participants’ errors according to target item 
and distracter item valence. 
 Controls Patients 
Errors on Positive 
Target Items 
Total Errors 
Threat 
Neutral 
Positive 
18 
2 (11.11 %) 
10 (55.56 %) 
6 (33.33 %) 
25 
7 (28.00 %) 
10 (40.00 %) 
8 (32 %) 
Errors on Threat Target 
Items 
Total Errors 
Threat 
Neutral 
Positive 
23 
11 (47.83%) 
6 (26.09 %) 
6 (26.09 %) 
57 
24 (42.11 %) 
21 (36.84 %) 
12 (21.05%) 
 
 
 
3.3.3.2 Errors on New ToM Measure 
The ability to capture information on whether patients scored poorly because 
of an overall threat interpretation of an item on the New ToM measure is 
limited in its current format. However, observations by the author noted 
during the tasks illustrate that three patients and one control misinterpreted 
an overall positive valence ToM story in a threatening way (Item 3), whilst 
four participants (two patients and two controls) elaborated on threat valence 
items (items 4 and 5) in a similar vein. Table 6 describes participants’ 
comments. No observations were noted of any misinterpretations of stimuli in 
a neutral or positive valence direction.  
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Table 6: Misinterpretations of items on the New ToM Measure.  
Item  Scenario Observation 
3 Two characters work together to give a third 
character a nice surprise 
 Patient B: Described the two characters’ intention was to hit the third character 
with a stick. 
 Patient C: Reported “he’s attacked him”, referring to one of characters attacking 
another. 
 Patient D: Stated “he’s going to kick him” based on interpretation that one of the 
characters had stolen another’s juice. 
 Control A: Described the two characters’ intention was to “mug him” (third 
character).  
4  One character, holding a box, requests 
assistance to move boxes from two others.  
 Patient B: Stated the character holding the box intended to “steal something”. 
 Control A: Stated that the character holding the box intended to “steal that box”. 
 Control B: Stated “he’s expecting hostility” in reference to the character holding 
a box. 
5 One character is given a nasty surprise by 
two others, who offer the first a box of 
chocolates with a spider in it. 
 Patient A: Stated “maybe they’ve got her [the character who was deceived by 
the other two characters] as a hostage”. 
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3.3.3.3 New ToM Measure  
The New ToM Measure was developed as part of this study, and as such it 
was of interest to note how participants approached this task. All participants 
completed the measure, and none became distressed during the completion 
of any of the study tasks. It would therefore seem reasonable to infer from 
this that the measure was acceptable to participants. It was observed that 
several participants (both controls and patients) requested third-order false 
belief questions to be repeated. These take the form “what does person X 
assume person Y believes regarding his/her (person X) intentions”. These 
questions are of increased complexity, however, they minimise the likelihood 
of ceiling effects and are therefore usefully included in the measure (Bell et 
al., 2010). The New ToM Measure allows accuracy on the different 
components (questions or sequencing) to be scored separately and a 
detailed analysis of this is provided in Appendix 2.9.     
 
 
3.3.3.4 Post hoc analyses 
3.3.3.4.1 New ToM Measure Response Speed 
The amount of time taken to sequence items (response speed, seconds) on 
the New ToM Measure was recorded. Participants were instructed that 
although the amount of time taken to respond would be measured, the 
accuracy of sequencing should be prioritised over speed. The assumptions 
of normality and homogeneity of variance were not met, therefore differences 
within and between groups were explored using non-parametric tests (Mann-
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Whitney Test and Wilcoxon signed-rank test). Data was missing for one 
control participant. 
 
Average response speed across all items in the New ToM Measure was 
examined for both groups. There was no significant difference between the 
control group (Median, Mdn = 21.33) and patient group (Mdn = 26.17) in 
average response speed (p = .27). Average response speed was examined 
for both groups according to valence. A non-parametric alternative to a 
Mixed ANOVA was not available, therefore data were explored using multiple 
Wilcoxon signed rank tests. In the patient group, average response speed 
across threat items compared with positive items was examined. There was 
a significant difference in average response speed, with patients taking 
longer to respond on threat items (Mdn = 29.00) than positive items (Mdn = 
21.67) (p = .04). In the control group, average response speed was not 
significantly different on threat (Mdn = 23.67) and positive items (Mdn = 
17.00). 
 
 
3.3.3.4.2 Preliminary investigation of construct validity 
A preliminary investigation of the construct validity of the New ToM Measure 
was conducted. The New ToM Measure was based on the Picture 
Sequencing Task (PST) (Brüne, 2003), however, the PST was not employed 
in this study. Therefore, this preliminary analysis explores the correlation 
between the New ToM Measure and the Eyes Test. Overall accuracy data 
were pooled across groups for the purpose of this analysis, and a bivariate 
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correlation was conducted. Data met the assumption of normality. There was 
a significant correlation between the New ToM task and the Eyes Test (r = 
.59, p = .016). An exploratory analysis of the correlation between the two 
measures was conducted for controls and patients separately, however, 
these were not significant (Control group: r = .05, p = .90; Patient group r = 
.24, p = .57). 
  
 
  
4. Discussion 
A considerable body of evidence demonstrates that ToM ability is 
significantly impaired in individuals with schizophrenia versus healthy 
controls, although the nature of ToM deficits in patients with paranoid 
symptoms is unclear (Brüne, 2005). The purpose of this study was to 
examine ToM ability in individuals with paranoid schizophrenia compared to 
controls, and to explore whether this varied according to the emotional 
valence of items within ToM tasks.  
 
 
4.1 Hypothesis 1:  
The first hypothesis was that significant differences would be found in ToM 
ability in individuals with paranoid schizophrenia compared to controls. This 
study found evidence that controls are significantly more accurate than 
patients when overall accuracy is considered (Eyes Test: p = .001, d = 2.24, 
large effect; New ToM Measure: p = .003, d = 1.82, large effect). This pattern 
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was maintained when accuracy was explored according to emotional 
valence, with large between group effects in evidence again on the Eyes 
Test (p = .003, d = 1.89) and New ToM Measure (p = .004, d = 1.32). This 
study therefore lends further support to the existing body of evidence that 
has found individuals with schizophrenia to have impaired ToM ability (Bora 
et al., 2009), and strengthens the evidence that this is similarly the case in 
individuals with a diagnosis of paranoid schizophrenia.  
 
 
4.2 Hypothesis 2 and 3  
The second hypothesis of the study was that there would be a significant 
difference in ToM abilities in individuals with paranoid schizophrenia 
compared to controls, but that this would be mediated by the emotional 
valence of items within ToM tasks. The third hypothesis concerned the 
nature of this mediation, and proposed that individuals with paranoid 
schizophrenia would show greater accuracy on threat items compared to 
positive items.  
 
In the Eyes Test, an established measure of ToM, controls and patients 
differed significantly in accuracy, and a trend was found for the interaction 
between group and valence (p = .06). On closer examination, accuracy 
within the control group was similar for threat and positive items. However, 
the group with paranoid schizophrenia was more accurate on positive items 
compared to threat items. This difference was not statistically significant (p = 
.07), however a large effect was found (d = 1.01). Therefore, on the Eyes 
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Test, there would appear to be a trend towards ToM abilities being mediated 
by the emotional valence of items, although this was in the opposite direction 
to that hypothesised. There was no evidence from results on the New ToM 
Measure of a mediating role of emotional valence on ToM ability in terms of 
accuracy. For both controls and patients there were no significant differences 
within groups on their performance on positive versus threat items. 
 
 
4.3 Further considerations  
Control and patient groups were unmatched in terms of the WTAR 
(Wechsler, 2001), with the control group scoring significantly higher than the 
patient group (p = .02). It is possible therefore that the above differences 
between groups on ToM tasks were due to differences in pre-morbid levels 
of intellectual functioning. However, there is evidence from other studies to 
indicate that even when the confounding effects of executive functioning and 
intelligence are successfully controlled for, patients with schizophrenia still 
perform more poorly than healthy controls on ToM tasks (Brüne, 2005). The 
above interpretation of a difference between groups in ToM ability would 
therefore appear justified.  
  
When accuracy on ToM tasks was examined according to valence, there 
was a trend towards a mediating role of valence on ToM abilities in terms of 
accuracy on the Eyes Test. This suggests that there is a degree of variability 
in performance according to valence in the patient group, and provides some 
tentative support for the second hypothesis of the study. A large within group 
  
 79 
effect (d = 1.01) was found in the patient group, and although this difference 
also showed a trend it too did not quite reach significance.  There was no 
evidence of a mediating role of valence on ToM abilities in terms of accuracy 
on the New ToM measure.  
 
The nature of the trend in the patient group on the Eyes Test was contrary to 
hypothesised, with participants with a diagnosis of paranoid schizophrenia 
performing with greater accuracy on positive valence items than threat 
valence items. The nature of the trend in these results is consistent with 
existing literature that suggests that people with schizophrenia recognise 
facial emotions less accurately than healthy controls (Kohler et al., 2010). 
For example, Premkumar et al. (2008) found that outpatients with a 
diagnosis of schizophrenia or schizoaffective disorder performed less 
accurately than healthy controls on a Facial Emotion Attribution task. 
Specifically, they noted that patients were significantly less accurate than 
controls at recognising fear and anger, but did not differ for happy and 
neutral facial expressions. It may be that the results on the Eyes Test found 
in this study evidence that the effect of facial emotion recognition deficits 
exceeds any bias to attend to threatening stimuli (Bentall et al., 2009; Bentall 
and Kaney, 1989, cited in Phillips et al., 2000).  
 
Alternatively, it may be that the patient group’s lower pre-morbid intellectual 
functioning contributed to the group’s larger variation in accuracy scores on 
threat items. This larger amount of variation, perhaps amplified by the small 
sample size, may have contributed to a trend being detected. Any 
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interpretation of this result must be cautiously made given the small sample 
size, which could increase the chance of a Type 1 error. Response speed 
was not recorded for the Eyes Test, however, on the New ToM Measure, no 
between group difference was found for average response speed across all 
items. This suggests that any difference is not due to impulsive responding. 
Furthermore, patients spent longer considering the sequencing of threat 
items compared with positive items. This may indicate that they experienced 
these items as more difficult, although patients’ accuracy on threat and 
positive items on the New ToM Measure was similar. 
 
The absence of a similar trend towards a mediating role of valence in the 
patient group on the New ToM measure may be due to the fact that the two 
tasks employed in this study are based on two different paradigms: the New 
ToM Measure was primarily a social cognitive ToM task, whilst the Eyes Test 
was primarily a social-perceptual ToM task (Bell et al., 2010). Social 
cognitive tasks require the participants to assimilate contextual aspects 
about characters in a task (e.g. what a character knows or has done) in order 
to infer mental states (Bell et al., 2010), whilst social-perceptual ToM tasks 
involve inferring mental states from cues, such as photographs of eyes.  
 
 
4.4 New ToM measure 
When overall accuracy on the New ToM Measure and the Eyes Test was 
examined, a similar pattern of controls demonstrating greater accuracy than 
patients was evident. These results indicate that when the New ToM 
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Measure is scored in full, it is able to distinguish between control and patient 
groups. In addition, the inclusion of third-order false belief questions appears 
to have minimised ceiling effects. However, the New ToM Measure could be 
improved by capturing more information on the errors that participants make. 
For example, although the original sequence that photographs are placed in 
by participants is scored, the ‘story’ that the participant saw when they 
placed the photographs in a particular order is lost. A simple adjustment, of 
asking the participant to recount their interpretation of the story in the 
photographs, and recording this qualitative information would allow future 
users of the measure to determine whether an overall threatening or positive 
story was developed by a participant. The measure was acceptable to 
participants, and all appeared to engage well in trying to sequence the 
stories and answer the associated questions.  
 
 
4.5 Limitations 
There were several limitations to this study. Firstly, the patient and control 
groups were not matched in terms of intellectual functioning as determined 
by WTAR scores (Wechsler, 2001). The patient group were predominantly 
in-patients on rehabilitation wards, and as reported by Kalidindi et al. (2012), 
the majority of individuals receiving in-patient mental health rehabilitation 
services will have a history of psychotic symptoms which are not controlled, 
and will present with severe psychotic symptoms, which will have a major 
impact on role functioning. It is possible that recruiting a less severely ill 
patient group, such as a community patient sample may have overcome the 
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limitation of groups being unmatched (Kalidindi et al., 2012). The WTAR 
(Wechsler, 2001) assumes normal pre-morbid development of reading skills, 
however patients recruited to this study are likely to have experienced 
disrupted education. It may be that using an alternative estimate of pre-
morbid ability would have facilitated the process of matching control and 
patient groups.  
 
 A second limitation to this study was that the recruitment target was not met 
in the study period. The decision to stop recruitment was based on several 
considerations. Firstly, a preliminary analysis of the above data revealed that 
whilst patients performed poorly on the threat items, there was a large 
amount of variation in the data. In comparison, consistent levels of accuracy 
were achieved by patients and controls across positive and threat items on 
the New ToM Measure, again with large variation in accuracy data. This 
suggested that any mediating role of valence was likely to be small, and that 
a significantly larger sample would be needed to detect such an effect. In 
parallel, it was noted that recruitment of participants who met the study’s 
inclusion and exclusion criteria had been exhausted at study sites. Further 
recruitment would therefore have necessitated the involvement of additional 
sites, which would not have been possible in a study of this scope. The 
decision was therefore taken to stop recruitment to the study.       
 
A significant proportion of participants declined to participate in the study, 
with several citing concerns regarding confidentiality and lack of familiarity 
with the researcher. This is a recognised barrier in studies relating to 
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schizophrenia (Woodall et al., 2010). Several steps were taken to overcome 
these barriers, such as known healthcare team members initially introducing 
the project and researcher, and the researcher meeting with participants to 
discuss the project and address any questions or concerns, but despite this 
the number declining remained high. Alternative adjustments, such as 
providing general guidance regarding research participation may help to 
improve participation.  
 
An investigation of the construct validity of the New ToM Measure was 
conducted by examining the correlation between the New ToM Measure and 
the Eyes Test. The New ToM Measure was based on the Picture 
Sequencing Task (PST) (Brüne, 2003), however the PST was not employed 
in this study. The analysis of construct validity between the New ToM 
Measure and the Eyes Test can therefore be considered as preliminary only, 
and is acknowledged as another limitation to the study. Goodwin and Leech 
(2006) outline that values of r will be greater if there is more variability among 
the observations than if there is less variability. The amount of variability in 
the pooled analysis was greater than for the individual analyses of the control 
and patient group, which may have contributed to a greater value of r being 
found for the correlation between the New ToM Measure and Eyes Test 
across groups (r = .59, p = .016) than for controls (r = .05, p = .90) and 
patients (r = .24, p = .57) separately. Furthermore, correlation estimates are 
often inaccurate in small sample sizes (Schönbrodt and Perugini, 2013) and 
so the results obtained, especially for the separate analyses of control group 
and patient group, should be considered as exploratory only. Future research 
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could potentially explore the relationship between the New ToM Measure 
and other tasks, such as the PST. 
 
 
4.6 Conclusion 
The study provides evidence of theory of mind impairments in individuals 
with paranoid schizophrenia on an established ToM task, the Eyes Test, and 
a New ToM Measure, with large between group effects found. There was a 
trend in the patient group towards a mediating role of emotional valence on 
accuracy on the Eyes Test, however this was not in the hypothesised 
direction. There were several limitations to this study including the small 
sample size and samples being unmatched for pre-morbid intellectual 
functioning, which must be considered when interpreting these results.  
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Abstract 
In Scotland, healthcare policy and Government commitments reflect the 
current drive to increase the availability and provision of evidence based 
psychological therapies (Scottish Government, 2011). In order to make a 
meaningful contribution to this agenda, Wells (2010) argues that clinical 
psychologists’ roles must be extended by concentrating direct clinical work 
on those with the most complex presentations, and by supporting the wider 
workforce to deliver psychological care via the provision of training, 
supervision, consultancy and clinical leadership. I believe that the clinical 
psychologists’ core competence of ‘communication’ underpins the 
individuals’ ability to engage with this role expansion (British Psychological 
Society, 2008). In this reflective account, the development of this core 
competence will be explored via reflections on communication with clients, 
within supervision and the multi-disciplinary team.  
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Abstract 
There is an expectation that Clinical Psychologists will contribute to the 
current Scottish healthcare policy and Government commitments to increase 
the availability and provision of evidence based psychological therapies by 
supporting the wider workforce to deliver psychological care by providing 
training, supervision, consultancy and clinical leadership (Wells, 2010). 
Formulation is one of the key competence domains for applied psychologists 
(BPS, 2008), and promoting formulation skills and a psychological based 
understanding in clients, other professionals and teams is central to 
achieving good psychological care in Scotland. In this reflective account, I 
will consider how I have contributed to training formulation skills in others 
over the course of my first year and third year placements in adult mental 
health. Informal opportunities for ‘chipping in’ formulations will be considered 
in this account (Christofides et al. 2012).  
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Appendix 1.1: Clinical Trials Assessment Measure scores 
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Sample Available 
Score  
1 Type of sample: 
 Geographic cohort (all patients in a particular area) 
OR 
 Convenience Sample (e.g. clinic attenders or referred patients) 
OR 
 Highly selective (e.g. volunteers) 
5 
OR 
2 
OR 
0 
2 2 2 2 0 2 0 2 0 
2 Sample size:  
Sample size is greater than 27 participants in each treatment group or based on 
described and adequate power calculations 
5 0 
 
0 0 0 0 0 5 0 0 
Allocation 
1 There is true randomisation or minimisation allocation to treatment group.  10 10 10 10 0 0 10 10 0 0 
2 The process of randomisation is described 3 0 0 3 0 0 0 3 0 0 
3 The process of randomisation is carried out independently from the trial research 
team 
3 3 0 0 0 0 3 3 0 0 
Assessment (for the main outcome) 
1 The assessments are carried out by independent assessors and not therapists 10 10 0 0 0 0 10 0 0 0 
2 Standardised assessments are used to measure symptoms in a standard way 
OR 
Idiosyncratic assessments of symptoms 
 
6 
OR 
3 
6 6 6 6 6 6 6 6 6 
3 Assessments are carried out blind (masked) to treatment group allocation 10 10 10 0 0 0 10 0 0 0 
4 The methods of rater blinding are adequately described  3 0 3 0 0 0 0 0 0 0 
5 Rater blinding is verified 3 0 0 0 0 0 0 0 0 0 
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Control Groups Available 
Score 
1 ‘Treatment as usual’ is a control group 
AND / OR 
A control group that controls for non-specific effects or other established or 
credible treatment 
6 
AND 
/OR 
10 
6 10 6 10 0 10 10 6 0 
Analysis 
1 The analysis is appropriate to the design and the type of outcome measure 5 5 5 5 5 5 5 5 5 5 
2 The analysis includes all those participants as randomised (i.e. Intention to treat 
analysis) 
AND 
An adequate investigation and handling of drop outs from assessment if the 
attrition rate exceeds 15% 
 
6 
 
AND 
 
4 
6 0 6 0 0 6 6 0 0 
Active Treatment 
1 The treatment was adequately described 3 3 3 3 3 3 3 3 3 3 
2 A treatment protocol or manual was used 3 3 3 3 3 3 3 0 0 3 
3 Adherence to the treatment protocol or treatment quality was assessed 5 0 0 0 0 0 0 0 0 0 
Total 64 52 44 29 21 68 51 22 17 
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Appendix 2.0: Eyes Test pilot 
A pilot was conducted to classify items from the Eyes Test (Baron-Cohen et 
al., 2001) into three emotional valence categories: positive, neutral and 
threat. A convenience sample of 10 individuals rated each item according to 
the procedure employed by Harkness et al. (2005), although a 7-point scale 
from 'very threatening' to 'very positive' was employed. Stimuli that had mean 
ratings significantly below neutral were categorised as threatening, those 
significantly above neutral were categorised as positive, and those that did 
not differ significantly from neutral were classified as neutral items. If data 
met assumptions for parametric tests then one sample t-tests were 
employed, alternatively the Wilcoxon Signed Rank Test was employed. 
Table 1 provides details the classification of each item. Twelve items were 
classified as threat valence and eight items as positive valence. 
 
Table 1: Classification of Eyes Test items according to emotional valence. 
 
Valence Adjective (item number)  
Threat*  Upset (2) 
Insisting (4) 
Worried (5) 
Uneasy (7) 
 
Sceptical (12) 
Accusing (14) 
Doubtful (17) 
Tentative (19) 
Hostile (26) 
Distrustful (34) 
Nervous (35) 
Suspicious (36) 
Positive * Playful (1) 
Desire (3) 
Anticipating (13) 
 
Contemplative (15) 
Friendly (20) 
Interested (28) 
Reflective (29) 
Flirtatious (30) 
Neutral Fantasizing (6) 
Despondent (8) 
Preoccupied (9) 
Cautious (10) 
Regretful (11) 
Thoughtful (16) 
 
Decisive (18) 
Fantasizing (21) 
Preoccupied (22) 
Defiant (23) 
Pensive (24) 
 
Interested (25) 
Cautious (27) 
Confident (31) 
Serious (32) 
Concerned (33) 
* all items p < .05.  
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Appendix 2.1: New Theory of Mind Measure pilot. 
The New ToM Measure was based on the Picture Sequencing Task (PST) 
(Brüne, 2003). The scenarios in the New ToM Measure mirrored those of the 
PST in incorporating scenarios of mutual cooperation, deception and 
cooperation of two characters while cheating a third. The key differences 
were that the New ToM Measure was balanced in having three threat and 
three positive scenarios, and employed photographs instead of cartoons. 
Provisional storyboards of the scenarios were developed and photographed. 
Each scenario was depicted across four photographs.  
 
Individuals in the pilot were requested to place the four photographs for each 
item in a logical sequence. Following the results of the pilot, three items were 
amended in order to enhancing cues to the correct sequence order. The 
changes included having subjects in the photos move from the background 
to the foreground, and by minimising background information. The manual 
was taken from Brüne (2003) and questions were modified to reflect the new 
scenarios.  
 
 
  
108 
 
Appendix 2.2: New Theory of Mind Measure example item 
 
 
 
 
Figure 1. Item 2 from New ToM Measure – a nice surprise 
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Appendix 2.3: New Theory of Mind Measure manual 
  
 
 
 
Theory of Mind in individuals with paranoid schizophrenia 
 
Theory of Mind Measure – Manual and Scoring Form 
 
 
 
 
 
 
Primary Researcher – Ms Liesbeth Scott 
Chief Investigator - Dr Sue Turnbull 
Co-Investigator – Professor Andrew Gumley 
Field Supervisor – Dr Allison Blackett 
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Please note that this manual is taken from the manual for the Picture Sequencing 
Task that was kindly provided by Professor Martin Brüne for use in this study 
(Brüne, 2003). The manual has been adapted slightly to reflect the stimuli employed 
in this study.  
 
Administration Notes:  
Instructions to be read to the client are italicised. 
 
Administer pilot item and then six items.  
Pilot item: see corresponding score sheet 
To be read to the participant:  
 
I have four cards. I am going to put the four cards in front of you.  
 
Place the cards in order using the numbers 1, 2, 3, and 4. Cards should be placed 
face up and in a line in front of the participant.   
 
When I say ‘begin’, please arrange the cards in the correct order so that they 
show a logical sequence of events”. Put them in the order that you think is 
most sensible. 
 
When you think you are done, please say ‘finished’. I’ll be using a clock to 
measure the time you take, but it’s more important to get the cards in the 
correct order than it is to be fast. 
 
 Do you understand the instructions?  
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If yes, proceed as below. If no, repeat instructions as above, then proceed as below. 
 
Here are the cards for the first story. 
  
Place cards on table in front of the participant. Remember to start timing when you 
say ‘Begin’. 
 
Begin 
 
When the participant has completed the task, by saying ‘finished’, confirm that the 
cards are in the correct order. There are letters on the reverse of the cards. Check 
the sequence in order to confirm whether the cards are in the correct order. For the 
pilot item the correct order is POUR. 
 
If correct order, then proceed to first test item after saying:  
 That’s right 
If incorrect, then put the cards in the right sequence in front of the client and say 
This is the right order. They go this way to tell a story. 
 
Use the pilot item to illustrate to the client that each photo adds some additional 
information, but that you need to look across all four to work out what happens in 
the story. Say:  
You need to look at all four of the cards in order to see what is happening 
across them, it’s like putting together a comic-strip. You need to think about 
what might possibly be happening, and choose what makes most sense.  
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Advise client that you are moving to the first test item.  
 
Let’s try the next one. With the next ones, I will also ask you some questions 
about the story you see. 
 
Administration of Test Items: 
To be read to the participant:  
 
Let’s move on to the next story. There are six stories in total. You may find 
some easier and some more difficult. Each time, arrange them in an order 
that makes the most sense. Work through each story in your own time. Do 
you have any questions? 
 Let’s start.  
 
Place the cards on the table in front of the participant in order using the numbers 1, 
2, 3, 4 on the back of the cards.  
Say the following to the client, and be ready to start timing.  
 
Are you ready? Begin. 
 
 Start timing. 
 
When the client has finished the task, i.e. when they say ‘finished’, check the 
sequence of the cards.  
Item Number  Correct Sequence  Item Content 
 
Item 1:      HELP    Biscuit 
Item 2:      CAKE    Cake in box 
Item 3:      NICE    Present on bench 
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Item 4:      TRIP    Trip with broom 
Item 5:      YUCK   Bug in bag 
Item 6:      TAKE    Bike accident 
 
Record sequencing order, time to completion, and circle the scores for each item.    
 
For ease of scoring, correct scores are circled and incorrect ones are crossed out.     
Example-  
correct 
sequence 
H E L P 
patient’s 
sequence 
H L E P 
points (max. 
6) 
2 1 1 2 
Sequencing 
Time (Sec) 
45 
 Notes:  
 
If the picture story is sequenced incorrectly, move the pictures into the right order 
before starting with the questions. Point to the respective picture when asking the 
theory of mind questions, as indicated on the scoring sheet.  
 
Correct responses are provided on the scoring sheet as a guide.  
 
Once item complete, move to the next item.  
 
Pilot item 
Administer pilot item as described above.  
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Item 1 
Correct 
Sequence 
H E L P 
Participant‘s 
Sequence 
    
Score 2 1 1 2 
Sequencing 
Time (Sec) 
 
 Notes:  
Questions: 
 
Score (0 or 1) 
1. What does the person with the black shirt believe the 
one in the grey shirt intends to do? (2nd order belief) 
(Pointing to second picture). 
Correct answer – Get biscuits from high shelf.  
 
2. What does the person with the black shirt expect from 
the person in the grey shirt (reciprocity) (pointing to 
the fourth picture). 
Correct answer – Give him a biscuit, share with him. 
 
 
Sequencing Score  
Questions Score:  
Time:   
Total Score Item 1:  
Other observations:  
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Item 2 
Correct 
Sequence 
C A K E 
Participant‘s 
Sequence 
    
Score 2 1 1 2 
Sequencing 
Time (Sec) 
 
 Notes:  
Questions: 
 
Score (0 or 1) 
a) What does the person in white believe is in the box? 
(false belief) (pointing to photograph 3). 
Correct Answer: Work paper/ files. 
 
b) What’s in the box? (reality) (pointing to the third 
photograph). 
Correct Answer: Cake 
 
c) What does the person in white believe the person in 
red intends to do? (2nd order false belief) (pointing to 
third photograph). 
Correct Answer: Give him papers/work files. 
 
d) What does the person in red assume the person in 
white believes, regarding her (person in red) 
intentions? (3rd order false belief) (pointing to the 
second photograph). 
e) Correct Answer: Give him work paper/files 
 
f) What do you think the person in red intended to do? 
(deception) (whole story). 
Correct Answer: Do something nice for him, give him a 
nice surprise. 
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Sequencing Score  
Questions Score:  
Time:   
Total Score Item 2:  
 
Other observations:  
 
Item 3 
Correct 
Sequence 
N I C E 
Participant‘s 
Sequence 
    
Score 2 1 1 2 
Sequencing 
Time (Sec) 
 
 Notes:  
Questions  
 
Score (0 or 1) 
a) What does the person in the blue coat intend to 
do? (intention) (pointing to 1st picture). 
Correct Answer: Give a present. 
 
b) What does person in green believe has happened? 
(false belief) (pointing to 3rd picture).  
Correct Answer: tripped over branch, injury, fell 
over 
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c) What do the person in the blue and the person in 
black intend to do? (distraction) (pointing to 2nd 
picture).  
Correct Answer: Distract the person in the green 
shirt and give him a present. 
 
d) What does the person in blue expect from the 
person in black? (Reciprocity) (pointing to 4th 
photograph).  
Correct Answer: To help him give the surprise 
present. 
 
e) What does the Person in green now think that the 
Person in blue and the person in black intended to 
do? (intention detection) (pointing to 4th picture). 
Correct Answer: To give him a present.  
 
  
Sequencing Score  
Questions Score:  
Time:   
Total Score Item 3:  
 
Other observations:  
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Item 4 
Correct 
Sequence 
T R I P 
Participant‘s 
Sequence 
    
Score 2 1 1 2 
Sequencing 
Time (Sec) 
 
 Notes:  
Questions 
 
Score (0 or 1) 
a) What does the person in red believe the person in 
white intends to do? (2nd order belief) (pointing to 
picture 2). 
Correct answer – Move boxes.  
 
b) What does the person with the white shirt expect 
from the person in the red shirt? (pointing to 
picture 2) (Assistance). 
Correct Answer – Help, to carry boxes. 
 
  
Sequencing Score  
Questions Score:  
Time:   
Total Score Item 4:  
 
Other observations:  
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Item 5 
Correct 
Sequence 
Y U C K 
Participant‘s 
Sequence 
    
Score 2 1 1 2 
Sequencing 
Time (Sec) 
 
 Notes:  
Questions 
 
Score (0 or 1) 
a) What does the person in blue believe is in the box? 
(false belief) (pointing to 2nd photograph).  
Correct Answer: A sweet, chocolate (bug is 
incorrect).  
 
b) What is in the box (reality) (pointing to the 
second photograph). 
Correct Answer: Bug, insect, spider 
 
c) What does the person in blue believe the person in 
green intends to do? (second order false belief) 
(pointing to the 2nd photograph). 
Correct Answer: Offer a sweet/chocolates  
 
d) What does the person in green assume the person 
in blue believes regarding his (the one in green) 
intentions? (3rd order false belief) (pointing to the 
2nd photograph). 
Correct Answer: Give her sweet/chocolates. 
 
e) What do you think the person in green intended to 
do? (deception) (whole story). 
Correct Answer: scare her, frighten her, shock her. 
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 Sequencing Score  
Questions Score:  
Time:   
Total Score Item 5:  
 
Other observations:  
 
Item 6 
 
Correct 
Sequence 
T A K E 
Participant‘s 
Sequence 
    
Score 2 1 1 2 
Sequencing 
Time (Sec) 
 
 Notes:  
Questions 
 
Score (0 or 1) 
a)  What does the person with the bike intend to do? 
(Pointing to first picture). 
Correct answer – Take laptop bag.   
 
b) What does the person with the red scarf believe has 
happened? (Pointing to the third picture) (false belief). 
Correct answer – An accident, an injury.  
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a)  What do the persons with the bike and grey coat intend 
to do? (Pointing to the second photograph) (cheating).  
Correct answer – Distract the person in blue and steal 
the laptop. 
 
b) What does the person in grey expect from the person 
with the bike? (Pointing to the fourth photograph). 
Correct answer – Help to steal the laptop, share the 
laptop.  
 
c) What does the person with the red scarf now think that 
the person with the bike and the person in the grey coat 
intended to do? (Pointing to the fourth photograph). 
Correct answer – Steal the laptop.  
 
  
Sequencing Score  
Questions Score:  
Time:   
Total Score Item 6:  
 
Other observations:  
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Overall Scoring:  
 Sequencing Questions Time 
Item 1    
Item 2    
Item 3    
Item 4    
Item 5    
Item 6    
 
 
Overall score 
 
Accuracy on Positive Items (Items 1, 2 and 3) - defined as the percentage of items where 
the participant identifies a correct response:  
 
 
Accuracy on Threat Items (Items 4, 5, and 6) – defined as the percentage of items where 
the participant identifies a correct response:  
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Appendix 2.4: Ethics approval 
  
124 
 
 
  
125 
 
 
  
126 
 
Appendix 2.5: NHS Research and Development approval 
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Appendix 2.6: Ethics approval of major amendment 
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Appendix 2.7: NHS Research and Development approval of major 
amendment 
From: O'Neill, Elaine [Elaine.O'Neill2@ggc.scot.nhs.uk] 
Sent: 07 June 2013 13:51 
To: Suzanne Scott 
Subject: Substantial Amendment - R&D Ref GN11CP446 Protocol V4; 19 May 13 Substantial 
Amendment AM03 (20/05/13) 
Dear Ms Scott, 
R&D Ref: GN11CP446    Ethics Ref: 11/WS/0115 
Investigator: Ms Suzanne Scott 
Project Title: Theory of Mind in individuals with paranoid Schizophrenia 
Protocol Number: V4; 19 May 13 
Amendment: Substantial Amendment AM03 (20/05/13) 
Sponsor: NHS Greater Glasgow and Clyde 
I am pleased to inform you that R&D have reviewed the above study's Amendment AM03 
(20/05/13) and can confirm that Management Approval is still valid for this study. 
 Reviewed 
Documents:                                                            
 Version Dated 
Ethics Favourable Opinion Letter   03 Jun 13 
Ethics Validation letter   29 May 13 
Notice of Substantial Amendment Form AM03 20 May 13 
Advertisement 1 19 May 13  
Letter of invitation to participant 1 19 May 13 
Participant Information Sheet: GP – Control Group 1 19 May 13 
Protocol 4 19 May 13 
SSI Form – GP Amendment     
 I wish you every success with this research project. 
 Yours sincerely, 
Research and Development  
NHS Greater Glasgow & Clyde 
Research & Development 
Western Infirmary 
1st Floor, Tennent Building 
38 Church Street 
Glasgow 
G11 6NT 
  
tel: 0141 211 6208 
Web: www.nhsggc.org.uk/r&d  
  
Please note that from the 27th May 2013, R&D will be operating an electronic record system. 
Please submit your R&D submission via e-mail from this date  
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Appendix 2.8: Eyes Test distracter items 
A list was developed of all distracter items selected by participants when the 
target item was either a threat valence or positive valence item. Items 
already categorised in the first pilot as threat or positive were automatically 
coded as such. The remaining list of distracter items was classified by two 
independent raters into valence categories. Two items were disputed, and 
following discussion, full agreement was reached.   
 
Table 4: Classification according to emotional valence of Eyes Test distracter 
items.  
Valence Adjective  
Threat  Aghast 
Alarmed 
Anxious 
Arrogant 
Depressed 
Dispirited 
Disappointed 
Embarrassed 
Guilty 
Hostile* 
Insisting* 
Irritated 
Nervous* 
Terrified 
Neutral Annoyed 
Apologetic 
Baffled 
Bored 
Convinced 
Decisive* 
Dominant 
Grateful  
Indecisive 
Indifferent 
Impatient 
Joking 
Puzzled 
Sarcastic 
Shy 
Positive Amused 
Affectionate 
Comforting 
Contented 
Contemplative* 
Encouraging 
Friendly* 
Playful* 
Relaxed 
*Classified in initial pilot to determine target item valence 
 
  
132 
 
Appendix 2.9: New Theory of Mind Measure analysis according to 
components 
 An ANOVA with Group (Control or Patient) as a between-factor and 
component (sequencing or questions) as a within-factor was conducted. The 
dependent variable was accuracy, defined as the percentage of items for 
which a correct response was given. There was a significant main effect of 
group (F (1, 14) = 11.35, p = .005), with controls (M = 77.60, SE = 6.34, 95% 
CI 64.01 – 91.20) performing more accurately than patients (M = 47.40, SE = 
6.34, 95% CI 33.80 – 60.93) (d = 1.55, large effect). There was also a 
significant main effect of component, whereby overall scores were greater on 
questions (M = 67.19, SE = 4.62, 95% CI 57.28 – 77.10) than sequencing (M 
= 57.81, SE = 5.08, 95% CI 46.91 – 68.72) (d = 0.67, medium to large 
effect). However, there was no significant interaction between component 
and group (F (1, 14) = 1.24, p = .29). Paired sample t tests revealed that 
controls were significantly less accurate on sequencing than questions (t (7) 
= -2.63, p = .03), whereas there was no significant difference in patients 
accuracy according to component (t (7) = -.96, p = .37) (Figure 1). 
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Figure 1: Mean accuracy of control and patients according to sequencing 
and question components on the New ToM Measure (95% CI are displayed). 
The control group is illustrated with a dashed line.  
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Appendix 2.10: Major Research Project proposal 
   
 
 
 
Theory of Mind in individuals with paranoid schizophrenia 
 
 
 
 
 
 
 
 
Primary Researcher – Ms Liesbeth Scott 
Chief Investigator - Dr Sue Turnbull 
Co-Investigator – Professor Andrew Gumley 
Field Supervisor – Dr Allison Blackett 
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Theory of mind and schizophrenia 
'Theory of mind' (ToM) refers to the "cognitive capacity to represent one's 
own and other persons' mental states, for instance, in terms of thinking, 
believing, or pretending" (Brüne, 2005, p. 21). A substantial body of evidence 
demonstrates that this ability is significantly impaired in individuals with 
schizophrenia versus healthy controls (Brüne, 2005; Sprong et al., 2007), 
even when the heterogeneity of tasks employed to assess ToM is accounted 
for (Bora et al., 2009). Whilst ToM deficits in schizophrenia are well 
established, contradictory results have been reported regarding ToM 
impairment in patients in the acute phase of schizophrenia and after 
remission, in relation to IQ, executive function and memory abilities (Bora et 
al., 2009). The nature of ToM deficits in patients with paranoid symptoms is 
also unclear, as some studies have reported impaired ToM capacity, whilst 
others have failed to confirm this link (Brüne, 2005). 
 
Several different paradigms have been used to assess ToM in 
schizophrenia, and these can be usefully grouped according to social 
cognitive or mental state reasoning tasks (e.g. assessing false belief, 
deception and intention understanding, and pragmatic speech 
comprehension), social perceptual or mental state decoding tasks (e.g. 
inferring mental states from cues, such as eye expressions), and real-world 
tasks (e.g. assessing structured interviews) (Bell et al., 2010). It is possible 
that the inconsistent results in individuals with paranoid symptoms could be 
related to the nature and content of these tasks, in addition to other 
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methodological limitations including insufficient power, incomplete reporting 
of clinical variables (e.g. cognitive data), differences in the battery of ToM 
tasks employed, and a lack of research regarding the psychometric 
properties of ToM tasks (Sprong et al., 2007; Bora et al., 2009).   
 
 
ToM and paranoid symptoms 
A number of cognitive processes are implicated in paranoid symptoms, 
including disruptions at the neurocognitive and social-cognitive levels, arising 
from deficits (e.g. poor attention) and/ or biases (e.g. a self-serving and 
personalising bias, and information-processing biases) (Peer et al., 2004). 
Bentall et al. (2009) conducted an analysis of a range of psychological 
mechanisms to determine the cognitive and affective processes associated 
with paranoia, and reported paranoid delusions to be associated with a 
combination of pessimistic thinking style (low self-esteem, pessimistic 
explanatory style, and negative emotion) and impaired cognitive performance 
(executive functioning, tendency to jump to conclusions, and ability to reason 
about the mental states of others).  
 
Individuals with schizophrenia are less accurate, relative to healthy controls, 
in recognising facial emotions (Mandal et al., 1998; Kohler et al., 2003). 
Interestingly, individuals with schizophrenia have been reported as over-
attributing disgusted expressions and under-attributing happy expressions to 
neutral cues (Kohler et al., 2003); whilst a tendency to misperceive emotions 
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(including happy, sad, fear and surprise emotions) as disgust rather than 
anger has been reported in individuals with paranoid symptoms (Peer et al., 
2004). This has been assessed using stimuli that consist of facial 
expressions that represent a range of emotions including happy, sad, angry, 
disgust or neutral (Kohler et al., 2003; Peer et al., 2004).  
 
The 'Reading the Mind in the Eyes' task (Baron-Cohen et al., 2001), which is 
similar to the paradigm described above, is contended to be an advanced 
ToM test because the stimuli consist of only pictures of the eyes (Bell et al., 
2010). It measures the ability to identify cognitive emotions that require 
inferences about others' beliefs or intentions (e.g. being embarrassed or 
pensive). Cognitive emotions can be distinguished from 'basic emotions', 
which do not require this kind of inference (e.g. happy or disgusted) (Craig et 
al., 2004). Craig et al. (2004) reported a poor performance on the Eyes tasks 
by individuals with a diagnosis of paranoid schizophrenia. However, no 
information was provided regarding whether performance varied according to 
the direction of emotion (e.g. positive, negative, and neutral) included in the 
Eyes task.  
 
In addition to a tendency to misperceive emotions, paranoid patients appear 
to make inflated estimates of the likelihood of future threatening events 
(Bentall et al., 2009), and demonstrate heightened attention to threatening 
stimuli (Bentall and Kaney, 1989; cited in Phillips et al., 2000). For example, 
in an emotional Stroop test, a significantly greater amount of time was 
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required for paranoid individuals to name the print colours of threatening 
versus depressive and neutral words (Bentall and Kaney, 1989; cited in 
Phillips et al., 2000). Many of the mental state reasoning ToM tasks involve 
the deception of characters. For example, Frith and Corcoran's (1996) False 
Belief and Deception Story (FBDS) task, commonly employed in 
schizophrenia research, involves six ToM stories (first-order and second-
order) being read to subjects, of which four involve a character being 
deceived and centre around a theme of stealing. First-order false belief tasks 
involve identifying the mistaken beliefs held by a character in a story, whilst 
second-order false belief tasks involve identifying the false belief of one 
character about the beliefs of another (Sprong et al., 2007; Bell et al., 2010). 
Performance on ToM tasks are not generally considered in relation to the 
specific emotional content of the task, and it is unclear whether this could be 
a factor affecting an individual's performance.  
 
Abdel-Hamid et al. (2009) used a five-factor model of the Positive and 
Negative Syndrome Scale to explore the association of symptom clusters 
and individual symptoms with ToM ability in schizophrenia. Contrary to their 
expectations, the authors reported that there was no significant association 
of positive symptoms and impaired ToM. Unexpectedly, there was a 
significant interaction of impaired ToM with items included in the 'emotional 
distress factor'. For example, there were significant inverse interactions 
between ToM deficit and the items 'tension' and 'depression', and a strong 
positive interaction between ToM and 'guilt', all of which were largely 
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independent of IQ or executive functioning (Abdel-Hamid et al., 2009). It is 
possible that several methodological factors could have contributed to these 
results, including that there was a relatively heterogeneous clinical sample 
that included a range of both positive and negative symptoms. In addition, a 
single measure of ToM was employed.  
 
The ToM task employed by Abdel-Hamid et al. (2009) was Brüne's (2003) 
Picture Sequencing Task, which comprises picture stories with questions to 
assess a range of false beliefs, reciprocity, deception and cheating detection 
(Bell et al., 2010). It is possible that the differing emotional content (e.g. 
neutral stories and stories involving deception) within this ToM task might 
have affected performance given the above evidence regarding an 
individual’s tendency to attend to threatening stimuli and misperceive 
emotions.  
 
 
Theoretical frameworks 
A number of different theoretical frameworks have been proposed in order to 
account for ToM deficits in schizophrenia. For example, Frith (1992) 
proposed that positive and negative symptoms in schizophrenia can be 
accounted for by abnormalities in brain function and circuitry that give rise to 
the individual's failure to monitor their own and other persons' mental states 
and behaviour (Brüne, 2005). In contrast, Hardy-Baylé et al. (2003), has 
proposed that ToM impairments in schizophrenia are primarily related to an 
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executive or planning deficit. Evidence in support of Frith's (1992) and Hardy-
Baylé et al.'s (2003) conceptualisations has been mixed (Brüne, 2005; Abdel-
Hamid et al., 2009), for example, contrary to Frith's prediction, individuals in 
remission have also shown ToM impairments relative to non-clinical controls 
(Sprong et al., 2007; Bora et al., 2009). This suggests that ToM deficits may 
be 'trait' rather than 'state' impairments, that is, enduring characteristics of 
the disorder versus being linked to the presence of symptoms (Bora et al., 
2009). 
 
An alternative approach to that of Frith (1992) and Hardy-Baylé has been 
outlined by Gumley (2010). Gumley (2010) has proposed that ToM 
impairments are rooted in compromised normative developmental pathways, 
characterised by negative interpersonal experiences (e.g. lack of secure 
base and/or the presence of relational trauma and loss during childhood and 
adolescence), which reduce an individual's ability to develop skill in 
representing one's own and other persons' mental states. Reflective 
functioning (RF) refers to the "psychological processes underlying the 
capacity to mentalize" (Gumley, 2010, p 51). RF has been found to be 
impoverished in several studies of individuals with borderline personality 
disorder, where the Adult Attachment Interview (AAI) has tended to classify 
individuals as preoccupied with attachment and the transcripts have been 
unresolved for loss and trauma (Fonagy et al., 1996; Dozier et al., 1999; 
cited in Gumley, 2010).  
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The theoretical frameworks proposed by Frith (1992) and Hardy-Baylé et al. 
(2003) are limited in their ability to account for the direction of the above 
findings, for example the tendency to misperceive a range of emotions as 
disgust. Clarifying whether ToM ability varies according to the emotional 
content of the specific items of a ToM task could contribute to explaining the 
inconsistencies that have been reported in the literature, and also contribute 
to a greater understanding of the theoretical frameworks that attempt to 
account for ToM impairments in individuals with schizophrenia.  
 
 
Aim 
To examine whether ToM ability in individuals with paranoid schizophrenia 
varies according to the emotional valence of items within ToM tasks.  
 
 
Hypotheses 
The research will address several hypotheses including: 
 There will be a significant difference in ToM abilities in individuals with 
paranoid schizophrenia compared to controls, but this will be 
mediated by the emotional valence of items within the ToM tasks.  
 There will be a significant difference in ToM ability in individuals with 
paranoid schizophrenia compared to controls.  
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 Individuals with paranoid schizophrenia will show greater accuracy on 
items within ToM tasks that include an element of threat versus items 
that have no threat. 
Additionally, the research will explore the types of errors made by 
participants.  
 
 
Plan of Investigation  
Participants and inclusion/ exclusion criteria 
Two groups of participants will be recruited, a clinical group and a control 
group. The clinical group will consist of participants with a diagnosis of 
paranoid schizophrenia. Participants will be recruited from Psychiatric 
Rehabilitation Wards, Rehabilitation Outreach Teams and from Inpatient 
Wards across NHS Greater Glasgow and Clyde sites (e.g. Gartnavel 
Hospital, Dykebar Hospital, Leverndale Hospital and Parkhead Hospital). 
Potential participants from Inpatient Wards will only be recruited if they are 
no longer in the acute phase of their illness and awaiting move to a 
Rehabilitation Ward as decided by a member of their healthcare team. The 
following inclusion criteria will apply to the clinical group: 
 Between 16 and 65 years of age 
 English as a first language 
 Able to provide informed consent 
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 A diagnosis of paranoid schizophrenia 
 No changes in medication during the study period 
The following exclusion criteria will be applied to the clinical group:   
 A history of traumatic brain injury 
 A learning disability 
 Active substance dependence 
A control group will be recruited from amongst NHS Greater Glasgow and 
Clyde staff and University of Glasgow staff and students, and from the 
friends and relatives (excluding first degree relatives) of participating 
patients. In addition, the control group will also be recruited from patients 
attending GP practices participating in the study. Similar inclusion and 
exclusion criteria will apply to the control group, except that they will be 
excluded if they have received a diagnosis of a mental health problem. The 
control group will be matched to the clinical group in terms of age and 
intellectual functioning as determined by scores on the Wechsler Test of 
Adult Reading (WTAR; Wechsler, 2001).  
 
 
Recruitment Procedures 
Approval of project 
Following approval of the Major Research Project Proposal from the 
Research Director and the West of Scotland Research Ethics Service, 
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Hospital Management approval will be sought by attending Senior 
Management Team Meetings across each site. Following approval, the 
Consultant Psychiatrist Meeting will be attended in order to provide relevant 
information relating to the project and promote recruitment.  
 
 
Participant recruitment 
The clinical group participants will be recruited via a number of methods. 
Firstly, the researcher will attend Community Meetings (attended by staff and 
service users) at the different sites, in order to provide a brief summary 
outlining the study and allow service users to opt-in to the study. At these 
meetings, service users will be asked to complete a form where they can a) 
elect to participate; b) request further information; or c) decline to participate. 
Secondly, a poster will be used to advertise the study. Thirdly, members of 
an individual’s healthcare team will be able to refer potential participants 
directly to the researcher. Members of an individual’s healthcare team will 
seek verbal consent from the potential participant for their details to be 
passed to the researcher prior to referring them to the researcher. Once a 
participant has indicated that they are interested in participating in the study, 
the relevant Psychiatrist will then be consulted to apply inclusion and 
exclusion criteria, and to assess capacity to consent to the study.  
 
The control group will be recruited from amongst NHS Greater Glasgow and 
Clyde staff and University of Glasgow staff and students, and from the 
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friends and relatives (excluding first degree relatives) of participating 
patients. In addition, the control group will also be recruited from patients 
attending GP practices participating in the study. Participants will be 
recruited via posters located within appropriate and approved NHS Greater 
Glasgow and Clyde and University of Glasgow settings and by asking 
participants if they can suggest friends or relatives (excluding first degree 
relatives) who can be directly contacted with information about the study. 
Friends and relatives of patients (excluding first degree relatives) will be 
informed that their decision not to participate in the study will not affect the 
care of their friend or relative who is a patient and is taking part in the study. 
In order to recruit participants from GP Practice settings, all patients 
attending a GP practice on a particular day will be handed a letter outlining 
the project and an information sheet regarding the study by GP Practice 
Reception Staff. GP practice patients will be able to opt-in to the study by 
completing an opt-in slip or identifying themselves to GP Practice Reception 
Staff, who will then inform the Primary Researcher. The Researcher will meet 
with participants on the same day, immediately after their GP appointment. 
The participant information sheet will be reviewed with each potential 
participant before consent to participate in the study is sought.  
 
 
Measures 
The following measures will be employed: 
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The revised Eyes task (Baron-Cohen et al., 2001), which has enhanced 
psychometric properties, will be employed to assess ToM (Bell et al., 2010). 
A pilot study using a convenience sample of 10 individuals will be employed 
to classify the items within the task into emotional valence categories: 
threatening (e.g. hostile, suspicious), positive (e.g. friendly, interested) and 
neutral (e.g. pensive, reflective). The classification of items will be guided by 
adapting the procedure described by Harkness et al. (2005).  Each stimuli 
will be ranked on a 7-point scale from 'very threatening' to 'very positive', and 
those that have mean ratings significantly below neutral will be classified as 
threatening, and those rated significantly above will be rated as positive. The 
piloted task is anticipated to take participants 15 minutes to complete.  
 
Brüne's (2003) Picture Sequencing Task will be employed as the basis for 
constructing a new ToM task that includes three positive ToM stories, and 
three threatening ToM stories. Each ToM story will be represented in a series 
of four photographs. Following the methodology employed in Brüne's (2003) 
Picture Sequencing Tasks, participants will be asked to place the cards in 
the correct order so that they show a logical sequence of events. Participants 
will then be asked a series of questions regarding each story in order to 
assess ToM ability (e.g. false beliefs, reality). It is anticipated that this task 
will take 15 minutes to complete. This measure will be piloted using a 
convenience sample of 10 individuals prior to use.   
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The Brief Psychiatric Rating Scale (BPRS) (Overall and Gorham, 1962) will 
be employed in order to assess psychopathology. The psychometric 
properties of the BPRS have been reported as adequate, and four factors 
are uniformly reported as positive symptoms, negative symptoms, 
depression-anxiety and agitation (Kopelowicz et al., 2008). Each participant's 
named nurse or other appropriate member of healthcare staff will be 
contacted in order to complete this rating scale. It is anticipated that this task 
will take 15 to 30 minutes to complete.  
 
The Wechsler Test of Adult Reading (Wechsler, 2001) will be employed to 
provide an estimate of pre-morbid level of intellectual functioning for 
individuals aged 16-89 years. It is a word-reading test that involves 
pronouncing irregularly spelled words. The task is anticipated to take 5-10 
minutes to complete.  
 
 
Design 
A mixed design will be employed with group as a between-factors (control, 
clinical) and valence as a within-factors (positive, threat). There will be two 
dependent variables accuracy on positive items, and accuracy on threat 
items, defined as the percentage of items where the participant identifies a 
correct response.  
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Research Procedures 
In the clinical group, once an individual has been identified as able to provide 
informed consent, the researcher will contact the individual to arrange an 
appointment. Informed consent will be sought at the start of the appointment. 
Once written informed consent has been provided, appointments will take 
approximately 30 minutes to minimise demand on the participant. ToM task 
presentation will be counterbalanced to minimise bias associated with 
fatigue. The Eyes Task will be administered according to the instructions 
provided by Baron-Cohen et al. (2001). Instruction to the new ToM task will 
be similar to those of Brüne's (2003) Picture Sequencing Task. Instructions 
will be provided verbally and in brief written format for reference. Participants 
will be debriefed regarding the purpose of the study, and thanked for their 
participation. A similar approach will be used for the control group, with 
informed consent being sought at the start of the appointment.  
 
For the clinical group, following receipt of an individual’s informed consent, 
their named nurse or other appropriate member of staff will be contacted to 
complete the BPRS (Overall and Gorham, 1962), and to arrange access to 
case notes in order to obtain relevant demographic (e.g. age, highest level of 
education) and clinical (age of illness onset, duration of illness, medication) 
information. If an individual provides consent, their friends/relatives 
(excluding first degree relatives) will be contacted to invite them to participate 
in the study. For the control group, relevant information will be sought from 
individuals. 
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Justification of sample size 
The main comparison of interest will be to explore whether there is a 
significant difference between accuracy on positive items and accuracy on 
threat items in individuals with a diagnosis of paranoid schizophrenia. 
Harkness et al. (2005) reported descriptive statistics for positive and negative 
items in the Eyes Task. Using these data, Cohen's d was calculated for the 
difference in scores between positive and negative items, and a large effect 
of 0.74 was detected. In order to conduct a MANOVA with independent 
variable of Group (Control, Clinical Group) and two dependent variables 
(accuracy on positive items, accuracy on threat items), and given an effect 
size of 0.4,  of .05 and power of 0.80 a total sample of 28 is required for the 
global effects, with 14 participants in each group (Faul et al., 2007). 
Harkness et al. (2005) also explored the difference in accuracy between 
dysphoric and non-dysphoric individuals. The authors reported a significant 
difference of t (41) = 2.85, p < .025, and using this, a value of 0.41 was 
calculated for r. This equates to a large effect size of Cohen's d > 0.8. 
Therefore the above sample size calculation would also appear to be valid 
for exploring the relationship between the control and clinical groups. 
  
 
Settings and Equipment 
The settings for the study will be a number of hospital sites across NHS 
Greater Glasgow and Clyde. ToM tasks will be administered in a free clinic 
room, to be arranged with each Hospital site.   
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Data Analysis  
The main analysis will employ a MANOVA in order to test whether there is a 
significant difference in ToM ability depending on the emotional valence. This 
test will be employed to accommodate two dependent variables. Non-
parametric alternatives will be explored if necessary.  
 
 
Health and Safety Issues 
The proposed study will be undertaken on different hospital sites within NHS 
Greater Glasgow and Clyde, therefore local Health and Safety policies and 
procedures will be adhered to.  
 
 
Researcher Safety Issues 
Researcher safety has been considered and a number of steps will be taken 
to promote it. Participants with a diagnosis of paranoid schizophrenia are to 
be recruited, however, a psychiatrist will be consulted prior to any contact 
with a participant in order to determine whether the individual has the 
capacity to consent to the study. No participants in the acute phase will be 
recruited. Additionally, the control group will be recruited from NHS Greater 
Glasgow and Clyde staff and University of Glasgow staff and students, from 
friends and relatives (excluding first degree relatives) known to participating 
individuals, and from patients attending their own GP practice. An identified 
and appropriate member of staff will be informed of all scheduled meetings 
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with participants. All appointments will be located on NHS Greater Glasgow 
and Clyde sites. Local health and safety policies will be adhered to by the 
Primary Researcher. The Primary Researcher will carry a pin-point alarm 
and will be familiar with appropriate procedures to raise alarm if necessary.  
 
 
Participant Safety Issues 
Participant safety will be promoted by conducting appointments in suitable 
settings on NHS Greater Glasgow and Clyde Hospital sites. The Primary 
Researcher will adhere to local health and safety policies. Participant fatigue 
will be minimised by limiting the duration of each participant in the study to 
approximately 30 minutes. The Primary Researcher will monitor participants 
for signs of fatigue or discomfort, and if indicated, the Primary Researcher 
will check whether the participant wishes to continue or discontinue with 
testing. Participants will be provided with written information at the point 
where consent is sought, which will highlight their right to withdraw from the 
study at any point. 
 
It is possible that a participant could become distressed during testing (for 
example, thinking that they are making errors). If the participant becomes 
distressed, the Primary Researcher will check whether the participant wishes 
to continue or discontinue with testing. Informed consent will be sought from 
all participants prior to testing and participants will be provided with written 
information that highlights their right to withdraw from the study at any point. 
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If the Primary Researcher has any concerns regarding the participant’s well-
being or presentation (e.g. they pose a risk to themselves or to others) then 
testing will be discontinued and the Primary Researcher will report their 
concerns to an identified and appropriate member of staff (e.g. Clinical 
Psychologist, Psychiatrist, Named Nurse).  
 
 
Ethical Issues  
Following approval of the proposal by the University of Glasgow, Academic 
Unit of Mental Health and Wellbeing, management approval will be sought 
from NHS Greater Glasgow and Clyde Research and Development, whilst 
ethical approval will sought from the West of Scotland Research Ethics 
Service. Several ethical issues have been considered such as capacity to 
provide written informed consent to participate in the study, possible fatigue 
during testing, and risk.  
 
Each individual's psychiatrist will be consulted to check that they have 
capacity for consent. Prior to testing, each participant's written informed 
consent to participate will be sought. Testing will be limited to 30 minutes in 
order to reduce the demand on the participant, and the researcher will also 
monitor participants for fatigue or discomfort. Any concerns, for example 
regarding a participant's risk of harm to self or others or their presentation 
during the study will be reported by the researcher to an identified and 
appropriate member of staff, with supervision by the NHS Field Supervisor.  
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Financial Issues 
There is no anticipated cost associated with accessing the measures 
described above. The Eyes task is available free of charge for research 
purposes from the Autism Research Centre. The main cost of the study will 
be associated with photocopying measures, developing photographs, 
printing consent forms and other study paperwork. 
 
 
Timetable 
Recruitment of participants would commence in January 2013. Recruitment 
is deferred to January 2013 in order to accommodate a period of maternity 
leave for the Primary Researcher. The anticipated end date of the study is 
27th September 2013. 
 
 
Practical Applications 
The proposed study has the potential to make a significant contribution to the 
current understanding of ToM ability in individuals with paranoid 
schizophrenia. Additionally, it is possible may help to inform interventions for 
ToM deficits in clients with Schizophrenia. For example, Metacognitive 
Training aims to enhance patient's awareness of cognitive biases and 
explore alternative strategies that enable the client to make more appropriate 
inferences (Moritz and Woodward, 2007). Evidence regarding the role of 
  
154 
 
emotion within ToM deficits in Schizophrenia may serve to refine such 
interventions.  
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